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 Mobile group II introns are retroelements that site-specifically insert into DNA 
target sequences. The group II intron mobility pathway is mediated by a 
ribonucleoprotein particle (RNP) composed of excised intron RNA and an intron-
encoded protein (IEP). The intron lariat inserts at a specific DNA target sequence and is 
then reverse transcribed by the IEP. Both the intron RNA and IEP are required for DNA 
target site recognition. I have identified the contact sites within the IEP responsible for 
recognition of two key positions in the DNA target, T+5 and T-23. IEP recognition of 
T+5 in the 3'-exon is required for endonuclease cleavage of the bottom-strand of the 
DNA target site, which generates a primer used for initiation of reverse transcription of 
the intron. The T+5 base is contacted by G498 in the LtrA DNA-binding domain and 
nearby residues, particularly K499, potentially bolster this interaction. Recognition of T-
23 in the distal 5'-exon is required for initial recognition of the DNA target site by the 
RNP. The T533 side-chain contacts the T-23 base and the L534 side-chain may also 
contribute to recognition through hydrophobic interactions with the C5 methyl group. A 
 vii 
mutant, L534H, that switches target site specificity to T-23G has been characterized. In 
order for the RNP to make these and other contacts in the 5'- and 3'-exons 
simultaneously, the DNA must be bent. I have dissected the role of DNA bending in the 
intron mobility pathway and found that the DNA is bent at two progressively larger 
angles as the reaction proceeds. The predominant bend angle at earlier time points places 
the bottom-strand DNA cleavage site at the protein endonuclease active site. The 
predominant bend angle of later time points places the cleaved DNA site at the RT 
domain active site for initiation of reverse transcription of intron cDNA. Finally, in a 
practical application of group II intron mobility, I have used reprogrammed group II 
introns ("targetrons") to target two genes in Bacillus subtilis to demonstrate the suitability 
of targetron technology for gene targeting in the Gram-positive Bacillus genus.  
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Chapter 1: Introduction 
1.1 MOBILE GROUP II INTRONS 
1.1.1 Introduction 
 Group II introns are fascinating ribozymes with a complex array of activities 
(Lambowitz and Zimmerly 2010). They self-catalyze two transesterification reactions for 
intron splicing to excise a branched intron lariat from an unprocessed transcript (Michel 
and Ferat 1995). They also catalyze the chemically identical reverse reaction to insert 
intron RNA into DNA. Sequence-specific reverse splicing of intron RNA into a double-
stranded DNA target site provides the basis for retrohoming, the primary mechanism of 
group II intron mobility (Lambowitz and Zimmerly 2010).  
 Some group II introns are capable of self-catalyzing forward splicing in the 
presence of high Mg2+ and/or salt concentrations, but splicing under physiological 
conditions requires the assistance of protein factors to facilitate intron folding 
(Lambowitz and Zimmerly 2010). Although proteins encoded within the genome of the 
host organisms can promote group II intron splicing (Jenkins et al. 1997; Perron et al. 
1999; Till et al. 2001; Huang et al. 2005), intron-specific splicing factors ("maturases") 
encoded within the introns themselves can single-handedly facilitate splicing (Saldanha et 
al. 1999). The intron-encoded protein (IEP) promotes splicing by stabilizing the active 
conformation of the intron RNA during intron folding (Noah and Lambowitz 2003). 
 IEPs also play essential roles in group II intron mobility through DNA binding, 
reverse transcriptase, and site-specific DNA endonuclease activities (Zimmerly et al. 
1995b; Guo et al. 1997). In retrohoming, the spliced intron RNA invades an intronless 
 2 
allele and is reverse transcribed by the IEP, ultimately producing a new genomic copy of 
the intron (Zimmerly et al. 1995b; Cousineau et al. 1998). The intron RNA and IEP both 
contribute to retrohoming target site specificity (Guo et al. 1997). Mobile group II introns 
can also retrotranspose, invading ectopic DNA sequences, but less efficiently and at a 
lower frequency than retrohoming (Dickson et al. 2001; Ichiyanagi et al. 2002; Zhong 
and Lambowitz 2003). 
 The Lactococcus lactis LtrB (Ll.LtrB) intron and its cognate IEP, LtrA, provide a 
well-characterized model system for studying mobile group II introns. An efficient 
method for reconstituting Ll.LtrB RNPs in vitro using purified components has also been 
developed (Matsuura et al. 1997; Saldanha et al. 1999). The protein-assisted splicing and 
retrohoming pathways of the Ll.LtrB intron have been, and continue to be, the subject of 
exhaustive genetic and biochemical study. Targeting rules for the Ll.LtrB retrohoming 
DNA target site have been determined, and coupled with an understanding of the Ll.LtrB 
intron RNA contribution to DNA target site specificity, this has led to the development of 
an Ll.LtrB-based gene targeting system, the "targetron" (Mohr et al. 2000). Targetrons 
are capable of targeting virtually any gene in a variety of organisms (Karberg et al. 2001; 
Perutka et al. 2004; Yao et al. 2006; Yao and Lambowitz 2007; Mastroianni et al. 2008). 
1.1.2 Group II intron structure  
 Group II introns fold into a conserved structure composed of six helical domains 
(DI-DVI) radiating from a central core with multiple long-range tertiary interactions 
between domains (Figure 1.1) (Michel and Ferat 1995; Qin and Pyle 1998; Lambowitz 
and Zimmerly 2010). DI provides the basis for active site assembly for both the splicing 
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and reverse splicing reactions. Together, DI and DV, which coordinates catalytically 
required divalent metal ions, form the minimal catalytic core of group II introns (Koch et 
al. 1992; Gordon and Piccirilli 2001). DII contributes to the assembly of the core active 
site during RNA folding through essential tertiary interactions. DIII, although not 
required for catalysis, is termed the "catalytic effector" and the reaction rate is reduced in 
its absence (Fedorova et al. 2003). The IEP open-reading-frame (ORF) is found in DIV 
along with a high-affinity binding site for the IEP. The binding site includes the ORF 
Shine-Dalgarno sequence, so that IEP binding regulates its own translation. The ORF 
itself is dispensable for intron catalysis (Wank et al. 1999; Singh et al. 2002). DVI 
contains a bulged adenosine residue, the branch-point adenosine, required for intron lariat 
formation (Michel and Ferat 1995).  
 Group II introns are divided into three subgroups, IIA, IIB, and IIC, based on 
specific structural variations including the number and arrangement of sequence elements 
in DI that are responsible for aligning the splice site at the intron active site (Lambowitz 
and Zimmerly 2010). The Ll.LtrB intron belongs to the IIA subgroup, which relies on 
base-pairing interactions from three sequence elements to align the exons in the active 
site for intron splicing. Exon binding sites 1 and 2 (EBS1 and EBS2, respectively) base 
pair with intron binding sites 1 and 2 (IBS1 and IBS2, respectively) in the 5'-exon, while 
! base pairs with !' in the 3'-exon (Figure 1.2). The same base-pairing interactions are 
also required for DNA target site recognition and reverse splicing in intron retrohoming 
(Lambowitz and Zimmerly 2010).  
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1.1.2 Group II intron splicing  
 Group II intron splicing proceeds via a reversible, two-step transesterification 
pathway (Figure 1.3), similar in mechanism to eukaryotic spliceosomal pre-mRNA 
splicing (Michel and Ferat 1995). The LtrA protein binds as a dimer to the partially 
folded Ll.LtrB intron RNA precursor at the high affinity binding site in DIV and makes 
secondary contacts in DI, DII, and DVI. LtrA binding stabilizes the active structure of the 
intron's catalytic core (Saldanha et al. 1999; Wank et al. 1999; Matsuura et al. 2001; 
Noah and Lambowitz 2003; Dai et al. 2008). In the fully-folded state, the 2'-OH of the 
branch-point adenosine is positioned to attack the phosphodiester bond of the 5'-intron-
exon junction. This step generates a partially spliced intron lariat-3'-exon intermediate. 
The 3'-OH of the freed 5'-exon then attacks the phosphodiester bond of the intron lariat-
3'-exon junction, simultaneously excising the intron lariat-IEP complex and ligating the 
5'- and 3'-exons (Michel and Ferat 1995).  
1.1.3 Group II intron retrohoming 
 Together, the excised intron lariat and IEP constitute the active ribonucleoprotein 
particle (RNP) required for intron mobility (Zimmerly et al. 1995a; Saldanha et al. 1999). 
Retrohoming predominantly follows a pathway in which the intron RNA reverse splices 
into a specific double-stranded DNA target site, followed by IEP endonuclease-
dependent target-primed reverse transcription (TRPT). Cellular DNA repair mechanisms 
incorporate the cDNA-intron RNA into the host genome (Figure 1.4) (Lambowitz and 
Zimmerly 2010). The RNP initially binds DNA non-specifically and scans for the 
relatively long (~45 bp) specific target site. Upon recognition of the correct DNA 
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sequence features, reverse splicing is initiated by a conformational change within the 
RNP (Aizawa et al. 2003). Initial recognition by the RNP occurs in the 5'-exon and 
requires contacts between the LtrA protein and specific bases of the DNA, as well as 
phosphate backbone interactions (discussed in further detail in Section 1.3). These 
interactions between the 5'-exon and the LtrA protein precede localized melting of the 
double-stranded DNA, exposing IBS1, IBS2, and !' in the top strand of the DNA target 
site to EBS1, EBS2, and ! in DI of the intron (Guo et al. 1997; Singh and Lambowitz 
2001; Zhong and Lambowitz 2003). EBS-IBS and !-!’ base pairing promotes reverse 
splicing by aligning the DNA insertion site with the intron RNA's active site.  
 After DNA target site recognition, the intron catalyzes the reversal of the two 
transesterification reactions used in intron splicing. In the first step of reverse splicing, 
the free 3'-OH of the intron attacks the phosphodiester bond of the insertion site in the 
DNA target top strand. The freed 3'-OH of the cleaved top strand DNA then attacks the 
2'-5' phosphodiester of the intron lariat branch point (Lambowitz and Zimmerly 2010). 
As in intron splicing, the transesterification reactions are reversible, with the intron 
capable of inserting and excising itself from the DNA target. Downstream reactions 
mediated by the IEP provide the forward driving force for the mobility process (Aizawa 
et al. 2003). 
 During or after reverse splicing, LtrA makes the necessary contacts in the 3'-exon 
of the DNA target site required for endonuclease cleavage of the bottom strand of the 
DNA target and the TPRT reaction (Singh and Lambowitz 2001; Aizawa et al. 2003). 
LtrA cleaves the bottom strand nine nucleotides downstream from the Ll.LtrB intron 
insertion site and initiates cDNA synthesis of the intron RNA using the free 3'-end of the 
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cleaved bottom-strand DNA as the primer (Lambowitz and Zimmerly 2004). In vivo, host 
DNA recombination and repair processes which vary in different organisms complete 
retrohoming by incorporating the intron RNA-cDNA into the genome (Eskes et al. 1997; 
Smith et al. 2005; Zhuang et al. 2009).  
1.2 LTRA, THE LL.LTRB INTRON-ENCODED PROTEIN 
 The LtrA protein consists of four domains: the reverse transcriptase (RT) domain, 
the maturase (X) domain, the DNA-binding (D) domain, and the endonuclease (En) 
domain (Figure 1.5). The N-terminal RT domain is composed of seven conserved motifs, 
RT1-RT7, with a large degree of homology to the fingers and palm regions of retroviral 
RTs. An additional upstream extension, RT0, is not found in long terminal repeat-
containing (LTR-containing) retroviral  RTs, but is conserved among the diverse family 
of non-LTR-retroelement RTs (which include the RTs of mobile group II introns, non-
LTR-retrotransposons, bacterial retrons, and retroplasmids). RT0 is implicated in the 
binding of the RT to the RNA template for initiation of cDNA synthesis (Michel and 
Lang 1985; Xiong and Eickbush 1990; Chen and Lambowitz 1997; Malik et al. 1999; 
Bibillo and Eickbush 2002). Domain X is associated with activities related to RNA 
binding, namely, maturase activity to facilitate intron folding. It also contributes to RT 
activity. Although domain X shares little sequence homology to retroviral RTs, it 
contains secondary structural elements similar to the retroviral RT thumb and is located 
downstream of the RT domain in the position corresponding to the retroviral RT thumb 
and connection domains (Mohr et al. 1993; Blocker et al. 2005). Both the RT domain and 
domain X are required for protein-assisted intron splicing (Cui et al. 2004).  
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The C-terminal region of the IEP lacks homology or structural similarity to 
retroviral RTs. The DNA-binding domain contributes to reverse splicing and bottom-
strand cleavage during intron mobility. Endonuclease cleavage of the bottom-strand 
requires the En domain. The En domain contains a Mg2+-dependent nuclease fold 
homologous to the Zn2+-dependent H-N-H endonuclease domain of colicin DNases 
(Singh and Lambowitz 2001; San Filippo and Lambowitz 2002). Mutations or deletions 
of conserved residues in the En domain that strongly inhibit En activity also inhibit RT 
activity to some degree, while RNA splicing and reverse splicing activities are largely 
unaffected. The relationship between En and RT activities may be explained by the need 
for proper positioning of the DNA primer by the En domain following bottom-cleavage 
so that the RT domain can initiate cDNA synthesis. However, the structure of the RT 
domain may also be sensitive to mutations in the En domain, analogous to the 
interdependent nature of the RT and RNase H activities of the HIV-1 RT (Ding et al. 
1997), where mutations in one domain can have a large impact on the activity of the other 
(San Filippo and Lambowitz 2002; Zhong and Lambowitz 2003). 
1.3 CRITICAL CONTACTS FOR LL.LTRB DNA TARGET SITE RECOGNITION 
Group II intron RNPs recognize DNA target sequences by using both the IEP and 
base-pairing interactions of the intron RNA (Guo et al. 1997). Key nucleotide residues of 
the Ll.LtrB intron target site have been identified by mutational, DNA footprinting, 
modification-interference, and missing-base analyses (summarized in Figure 1.2) (Mohr 
et al. 2000; Singh and Lambowitz 2001). The IBS/!' base-pairing region extends from 
positions -12 to +3, relative to the intron insertion site in the DNA top strand (Mohr et al. 
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2000). In both the distal 5'-exon and 3'-exon regions, the critical nucleotide residues 
recognized by IEPs differ even for closely related group II introns, suggesting that DNA 
target site specificity can evolve rapidly and may be readily changeable (Lambowitz and 
Zimmerly 2004).  
1.3.1 IEP contacts in the distal 5'-exon 
The most critical LtrA interactions in initial DNA target site recognition are found 
in the major groove of the distal 5'-exon extending from position -24 to -12, upstream of 
the IBS/!’ sequence (Figure 1.2). LtrA recognition of DNA features in this region of the 
DNA target site is required for both reverse splicing and endonuclease cleavage (Mohr et 
al. 2000; Singh and Lambowitz 2001).   
Specifically, modification-interference using KMnO4 identified T-23 and T-19, in 
the top strand, and T-20, in the bottom-strand, as significant pyrimidine contributors to 
5'-exon target site recognition (Singh and Lambowitz 2001). KMnO4 modification occurs 
at the C5-C6 double bond of the thymine base, which alters the major groove (McCarthy 
et al. 1990). Deoxyuridine substitution at T-23 strongly inhibits both reverse splicing and 
bottom-strand cleavage, while deoxyuridine substitution at the other two positions has no 
effect (Singh and Lambowitz 2001). Because deoxyuracil differs from thymine only in 
lacking the C5 methyl group, these findings suggest that initial LtrA protein recognition 
of the target site depends upon this distinguishing major groove feature of thymine at the 
-23 position.  
Missing-base and dimethyl sulfate (DMS) methylation-interference experiments 
identified G-21 and A-20 as required contacts for both reverse splicing and bottom-strand 
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cleavage. Other purines in this region, G-17 and G-15 in the top strand and A-16 on the 
bottom strand, were not protected from nor sensitive to DMS methylation, despite effects 
from missing bases at these positions. They may be recognized specifically in the minor 
groove or may play a structural role in LtrA recognition. Phosphate ethylation-
interference experiments indicate that the protein interacts non-specifically with the 
phosphate backbone along one face of the double helix in this same area (top strand -24 
and -21, bottom-strand -15  to -19, and top strand -13 and -14). This region of the 
phosphodiester backbone is unusually susceptible to cleavage by 5-phenyl-1,10-
phenanthroline in the absence of RNP binding and this may indicate an unusual backbone 
structure, which could contribute to recognition by the RNP. Overall, the results suggest 
that LtrA specifically recognizes T-23, G-21, and A-20 in the major groove of the top 
strand of the distal 5'-exon, bolstered by non-specific phosphate backbone interactions, 
early in the mobility reaction. These contacts are required for initiation of DNA melting 
to allow intron-DNA base pairing and/or stabilization of the DNA bottom strand as it  
becomes displaced by base pairing between the intron RNA and DNA top strand (Singh 
and Lambowitz 2001). 
1.3.2 IEP contacts in the distal 3'-exon   
Surprisingly few contacts between LtrA and nucleotide residues in the 3'-exon are 
highly sequence specific, with T+5 being the notable exception (Singh and Lambowitz 
2001). Recognition of T+5 is not required for initial recognition of the target site, but it is 
stringently required for bottom-strand endonuclease cleavage later in the retrohoming 
pathway (Mohr et al. 2000). Nuclease accessibility and hypersensitivity at the T+5 
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position when the DNA target is bound by the RNP suggest that the base is unpaired prior 
to the appearance of substantial levels of bottom-strand cleavage products. Furthermore, 
KMnO4 modification of T+5 or deoxyuridine substitution at T+5 both inhibit bottom-
strand cleavage to similar degrees but have no affect on reverse splicing. Taken together, 
these results indicate that bottom-strand endonuclease cleavage requires IEP recognition 
of T+5 and the C5 methyl group of the thymine base contributes to the interaction 
between the IEP and T+5 (Singh and Lambowitz 2001). 
LtrA interactions with other downstream positions in the 3'-exon top strand, 
T+11, T+12, and T+15, also contribute to bottom-strand endonuclease activity, but these 
are not strictly base specific and are not as critical as T+5 recognition. Interestingly, 
endonuclease cleavage of the bottom strand has no sequence specific requirement at the 
cleavage site itself (between the +9 and +10 positions) (Mohr et al. 2000; Singh and 
Lambowitz 2001).  
1.3.3 The Role of the IEP C-terminus in DNA recognition 
  Biochemical and genetic studies using C-terminally truncated LtrA suggest that 
the C-terminal DNA-binding and En domains interact with the DNA target site at various 
stages of the retrohoming reaction (Singh and Lambowitz 2001; San Filippo and 
Lambowitz 2002). LtrA truncations in which both the DNA-binding and En domains are 
deleted abolish reverse splicing into double-stranded, but not single-stranded DNA 
targets. Deletion of only the En domain has no effect on reverse splicing into double- or 
single-stranded DNA targets but inhibits bottom-strand cleavage (San Filippo and 
Lambowitz 2002). Moreover, the En domain is not required for interactions with the 
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distal 5'-exon summarized in Section 1.3.1 and En domain point mutations that inhibit En 
activity do not prevent DNA target site recognition of the distal 5'-exon, DNA 
unwinding, or reverse splicing (Singh and Lambowitz 2001; Zhong and Lambowitz 
2003). This pattern suggests that the DNA-binding domain is required for the local 
unwinding of distal 5'-exon DNA, and possibly for the stabilization of single-stranded 
DNA unwound by intron-DNA base pairing.  
1.4 OVERVIEW OF DISSERTATION RESEARCH 
This work addresses the mechanism used by the Ll.LtrB RNP to recognize and 
manipulate its specific DNA target sequence. In the first chapter, two sites found in the 
LtrA DNA-binding domain that interact with key DNA target sequence residues are 
identified. The peptide QGK (amino acid positions 497-499) contacts the T+5 base, while 
the peptide NTLENR (amino acid positions 532-537) contacts the T-23 base. To identify 
these contact sites, synthetic DNA target substrates with a site-specific photoactive 
nucleotide analog substitution, 4-thio-deoxythymine (4-S-dT), at either the -23 position, 
in the distal 5'- exon, or the +5 position, in the 3'-exon, were UV-cross-linked to the 
protein. The protein sites of the cross-links were then identified by electrospray- 
ionization ion-trap tandem mass spectrometry (ESI-ITMS/MS). Through mutational 
analysis of the identified recognition sites, these peptide contacts were confirmed and the 
nature of the interactions further characterized. Additionally, in light of the cross-linking 
results, a specificity switch LtrA mutant L534H was analyzed to better understand the 
nature of its altered specificity for the T-23G DNA target sites.  
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Chapter 2 examines the bending of the Ll.LtrB DNA target required to orient the 
DNA target successively into the intron active site for reverse splicing, the LtrA En 
domain active site for bottom-strand cleavage, and the LtrA RT domain active site for 
initiation of TPRT. I developed a model based on bending of the DNA target site as 
examined by atomic force microscopy (AFM). RNP-DNA complexes were immobilized 
on aminosilane-treated mica and imaged using tapping-mode AFM. This technique 
provides a snapshot of distinct molecular complexes at different points in the retrohoming 
reaction. By using a series of mutant RNPs and mutant or physically altered DNA 
substrates, the contributions of specific interactions to the bending of the DNA at 
different phases of the pathway were determined. 
In a practical application of the work of the previous chapters on RNP target site 
interactions, Chapter 3 examines the suitability of the Ll.LtrB-based targetron as a gene 
targeting vector for the Bacillus genus. Functional targetrons were developed for two 
genes in B. subtilis, ywpE and yhcS. Homologs for both genes are found in the closely 
related, pathogenic species, B. anthracis. These genes encode sortase proteins responsible 
for attaching proteins to the cell wall of Gram-positive bacteria. Elimination of sortase 
genes in pathogenic Gram-positive bacteria, such as B. anthracis, attenuates virulence, 
making them attractive therapeutic targets (Weiner et al. 2010). 
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Figure 1.1: Secondary structure model of the Ll.LtrB group II intron 
 
The six conserved helical domains of group II introns, labeled DI-DVI, emanate from a 
central hub. The model shown is specifically for the Ll.LtrB intron of the group IIA 
subclass, but the overall arrangement of the six domains is conserved among all three 
subclasses of group II introns. DI contains the sequence elements responsible for aligning 
the intron splice site, denoted  EBS1, EBS2 and ! in group IIA introns, which base pair 
with IBS1 and IBS2 in the 5'-exon (blue) and !' in the 3'-exon (red), respectively. DI and 
DV constitute the catalytic core of the intron, while DII and DIII contribute to intron 
folding and catalytic efficiency. The LtrA ORF and high affinity binding site are found in 




Figure 1.2: DNA target site interactions of the Ll.LtrB RNP 
 
The 45-bp DNA target site (-30 to +15, relative to the intron insertion site) is shown in 
complex with the Ll.LtrB RNP which is composed of the LtrA protein (green) and the 
Ll.LtrB intron RNA (DI stem loop motifs containing EBS2 and EBS1/! sequences shown 
in orange). The schematic below the DNA sequence denotes the IBS2 and IBS1 
sequences in the 5'-exon (blue) and the !' sequence in the 3'-exon (red), as well as the 
intron insertion site (IS) and endonuclease cleavage site (CS). The intron insertion site in 
the top strand of the DNA substrate and the endonuclease cleavage site in the bottom 
strand are also indicated by black arrows on the sequence. Nucleotide residues 
recognized by the LtrA protein through the major groove in the 5'-exon, T-23, G-21, and 
A-20, and T+5 in the 3'-exon, are highlighted in purple. Nucleotide residues that the 
protein contacts through the minor groove or non-base-specifically, G-17, G-15, and 
bottom-strand A-16, are highlighted in yellow. The LtrA protein interacts with the 




Figure 1.3: Group II intron splicing 
 
Protein-assisted intron splicing and intron self-splicing follow the same two-step 
transesterification reaction pathway. Both steps are reversible. In the first 
transesterification reaction, the 2'-OH of the branch-point adenosine residue attacks the 
phosphate of the 5'-exon-intron junction (G residue) forming the partially spliced intron 
lariat-3'-exon intermediate. Splicing is completed by the second transesterification 
reaction with the attack of the intron lariat-3'-exon junction by the terminal 3'-OH of the 
5'-exon, resulting in the ligation of the 5'- and 3'-exons and the release of the intron lariat 




Figure 1.4: Group II intron retrohoming 
 
The IEP binds the intron RNA in an unprocessed RNA transcript to promote splicing (see 
Figure 1.2). The IEP remains bound to the spliced intron lariat forming the retrohoming-
competent RNP. The RNP initially recognizes the DNA target site through interactions 
between the IEP and the 5'-exon, which lead to localized DNA unwinding. Base pairing 
between the intron EBS/! sequences and IBS/!’ DNA sequences align the intron active 
site for reverse splicing of the intron RNA into the top strand of the DNA target. The IEP 
cleaves the bottom strand between the +9 and +10  positions and uses the resulting 3'-OH 
to prime reverse transcription of intron cDNA (Lambowitz and Zimmerly 2010). Host 
DNA repair and recombination systems remove intron RNA and ligate the intron cDNA 
to genomic DNA to complete the retrohoming process (Eskes et al. 1997; Smith et al. 




Figure 1.5: Domains of the LtrA protein  
 
The Ll.LtrB IEP, denoted LtrA, is composed of four distinct domains, the reverse 
transcriptase (RT), maturase (X), DNA-binding (D), and endonuclease (En) domains, 
indicated above the protein schematic. Numbers above the schematic correspond to 
amino acid positions at domain boundaries. The highly conserved N-terminal RT domain 
is composed of seven conserved motifs (1-7) as well as an up-stream extension (0) which 
is conserved only among non-LTR-retroelement RTs. The RT domain and domain X 
bind the intron RNA, stabilizing its structure for splicing and reverse splicing. The C-
terminal D and En domains interact with the DNA target site during intron mobility 
(Lambowitz and Zimmerly 2010). 
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Chapter 2: Characterization of  IEP-DNA Target Site Interactions 
 
 As  shown in Figure 1.2, LtrA contacts T-23, G-21, and A-20 in the distal 5’-exon 
and T+5 in the 3’-exon of the DNA target site (Singh and Lambowitz 2001). To identify 
the contacts between specific amino acids of the LtrA protein and the DNA target site, I 
covalently cross-linked LtrA, in complex with the Ll.LtrB intron lariat, to DNA target 
sites containing a photoactive nucleotide analogue, 4-thio-deoxythymine (4-S-dT), at 
positions T-23 or T+5. Due to the longer activation wavelength (~365-nm) of 4-S-dT 
compared to native nucleotide residues, only cross-links between the specific DNA site 
and the LtrA protein were formed (Nikiforov and Connolly 1992; Wang and Biemann 
1994). I then analyzed the resulting cross-link by electrospray-ionization collision-
induced-dissociation ion-trap tandem mass spectrometry (ESI-CID-ITMS/MS) in the 
negative-ion mode. The identification of amino acids that interact with T-23 and T+5 
provides the first opportunity to disrupt specific, known IEP-DNA target site contacts. I 
biochemically and genetically characterized the effects of disrupting these interactions by 
mutational analysis of the recognition sites.  
 Understanding the complex web of interactions required for DNA target site 
recognition by the IEP has potential gene targeting applications. The LtrA specificity 
switch mutant L534H was identified previously through unigenic evolution of segments 
of the LtrA DNA-binding domain, but the structural underpinnings of the specificity 
switch were unknown (San Filippo 2003). L534H supports intron mobility into T-23G 
mutant DNA target sites with higher efficiency than into the wild-type (T-23) DNA target 
site, which suggests that L534 is at or near the T-23 recognition site. Here, I show that 
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L534 is adjacent to a site of cross-linking between the protein (T533) and the -23 position 
of the DNA target site. 
2.1 IDENTIFICATION OF KEY REGIONS OF THE DNA-BINDING DOMAIN 
The DNA-binding domains of related group II IEPs, including LtrA, contain two 
structurally conserved features, an upstream basic cluster of amino acid residues and a 
downstream predicted !-helix (Figure 2.1) (San Filippo and Lambowitz 2002). The 
secondary structure prediction program Jpred 3 (Cuff and Barton 1999; Cole et al. 2008) 
predicts that the conserved !-helix of the wild-type LtrA DNA-binding domain spans 
N532-K539. This predicted length is somewhat shorter than the published predictions for 
the !-helix from previous versions of Jpred, which were from P524-L538 or A523-L538 
(San Filippo and Lambowitz 2002; Blocker et al. 2005). 
Key residues in the basic cluster and putative !-helix have previously been identified 
by screening for active LtrA variants from libraries of partially randomized ("doped") 
LtrA variants (San Filippo 2003). In the basic cluster, the most strongly conserved 
residue was R502, while K496, G498, R501, Y503, and, A505, were conserved but with 
greater numbers of substitutions. The most variable residues were Q497 and K499. In the 
predicted !-helical region, E535, R537, and L538 were invariant and most of the 
remaining amino acid residues were conserved. The two most variable residues were 
Q522 and N532. In both doped regions, most of the amino acid substitutions selected in 
active variants were conservative and/or similar to substitutions observed previously in 
unigenic evolution analysis: e.g., T533S, N536D/I/T/K. 
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 Notably, of the active LtrA mutants isolated from the !-helical region doped library, 
55% contained a predicted !-helix spanning the positions predicted for the wild-type 
LtrA protein (positions 532-540). The core of the !-helix from positions 533 to 537 was 
predicted by the program for all active mutants in the sequenced library. Together, the 
above findings indicate that both the upstream cluster of basic amino acid residues and 
the predicted !-helical region are highly constrained in functional LtrA variants and 
provide additional insight into permissible amino acid substitutions in these regions. 
2.2 THE T+5 CONTACT SITE 
2.2.1 Identification of the T+5 cross-link site 
To directly probe interactions between the LtrA protein and the 3'-exon of the DNA 
target site, I site-specifically photo-cross-linked LtrA to a modified DNA substrate. The 
DNA substrate used for cross-linking is a synthetic double-stranded DNA oligonucleotide 
corresponding to the 45-bp Ll.LtrB intron target sequence with 4-S-dT substituted at the 
+5 position. The 4-S-dT+5 DNA substrate was incubated with Ll.LtrB RNPs for 15 min 
at 37°C to allow reverse splicing and bottom-strand cleavage, and photo-cross-linked 
using 365-nm UV light (see Section 2.5.4 for experimental details). The covalently linked 
protein-DNA conjugates were then digested with a combination of DNase I and 
micrococcal nuclease, and precipitated with trichloroacetic acid/acetone to remove free 
nucleotides. The pellet was resolubilzed, denatured, and reduced with dithiothreitol 
(DTT) for trypsin digestion. The resulting mixture of tryptic-digest peptides was enriched 
for 4-S-dT-peptide cross-links using TiO2 affinity chromatography. The enriched sample 
was then analyzed by mass spectrometry. 
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 Figure 2.2 shows the full negative-ion mode ESI-ITMS of the enriched peptide-4-
S-dT+5 cross-link mixture and the proposed cross-link structure. The peak at 634 m/z 
corresponds to the mass of the peptide QGK (330 Da), LtrA amino acid positions 497-
499, plus the mass of the 4-S-dT monophosphate (4-S-dTMP) adduct (304 Da). This 
peptide sequence is found within the basic cluster in the LtrA DNA-binding domain 
(Figure 2.1) (San Filippo and Lambowitz 2002; Blocker et al. 2005).  
 Expected CID fragment ions are observed in the tandem MS (Figure 2.3) (Lenz et 
al. 2007). Because the y2 backbone cleavage ion (508 m/z) includes the 4-S-dTMP adduct 
(Figure 2.3, inset), the cross-link is further localized to either G498 or K499. Cleavage 
occurs at the cross-link bond between the peptide and 4-S-dTMP adduct, releasing the 
unmodified peptide fragment (330 m/z). Fragmentation of the glycosidic bond produces 
the deoxyribose monophosphate ion (195 m/z) (Yousheng Hua 2000). 
2.2.2 Cross-link and biochemical analysis of LtrA mutants at the T+5 contact site 
To confirm that the cross-linked peptide is the contact site for the T+5 base, I 
constructed LtrA mutants in which alanine was substituted for the three amino acid 
residues of the QGK peptide, either individually or all together. Wild-type LtrA and the 
alanine-substituted mutants were then expressed, purified, and reconstituted into RNPs 
with Ll.LtrB RNA for biochemical analysis.  
RNPs reconstituted with these alanine-substituted LtrA mutants were cross-linked to 
the 4-S-dT+5 DNA substrate containing a 32P-label at the +5 phosphate position (see 
Sections 2.5.3 and 2.5.4 for experimental details) to identify alanine substitutions that 
disrupt LtrA-T+5 interactions. After cross-linking, nucleic acids were DNase I digested 
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and the protein was analyzed by SDS-PAGE and autoradioagrapy (Figure 2.4). Cross-
linking was observed by the transfer of the 32P label to the protein. The cross-linking 
efficiency was unaffected by the Q497A mutation. However, the G498A and K499A 
mutations virtually abolished cross-linking, which suggests a disruption of the T+5 
contact. The cross-linking efficiency of the QGK triple mutant was also significantly 
reduced. These findings agree with the MS data localizing the cross-link to either G498 
or K499.  
To ensure that the alanine-substitutions at these positions did not significantly alter 
tertiary interactions within the LtrA protein, these mutants were assayed for RT activity. 
The RT activity of purified wild-type and alanine-substituted LtrA was assayed by using 
the artificial template substrate poly(rA)/oligo(dT)45 and quantifying polymerization of 
32P-dTTP in the linear range (Figure 2.5). The results show that the RT activity of all four 
mutant proteins was as high or higher than that of wild-type LtrA, which indicates that 
these alanine substitutions did not disrupt global protein folding.  
The reverse splicing and DNA endonuclease activities of these alanine-substituted 
LtrA mutants were determined in order to demonstrate the biochemical effects of 
disrupting the T+5 interaction (Figure 2.6). RNPs were incubated for 5 min at 37°C with 
an internally 32P-labeled, 129-bp DNA substrate containing the wild-type target site, and 
the products were separated in a denaturing 10% polyacrylamide gel (see Section 2.5.6 
for experimental details). The Q497A, K499A and QGK substitutions inhibited both 
reverse splicing (92 ± 13%, 33 ± 5%, and 36 ± 16% of wild type, respectively) and 
bottom-strand cleavage (47 ± 16%, 8 ± 6%, and 8 ± 6% of wild type, respectively). The 
G498A substitution also inhibited bottom-strand cleavage (58 ± 4% of wild type), but this 
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was coupled with dramatically higher reverse splicing (242 ± 26% of wild type). This 
phenotype of decreased bottom-strand cleavage but increased reverse splicing has been 
observed previously with wild-type Ll.LtrB RNPs and DNA target sites having mutant 
nucleotide residues at T+5 (Mohr et al. 2000; San Filippo and Lambowitz 2002) and, 
similarly, for the yeast mitochondrial group II intron aI2 when single nucleotides from 
the 3'-exon of its DNA target site (+1 to +4) were deleted (Guo et al. 1997). Together 
with the analytical cross-linking data, this phenotype strongly suggests that the G498A 
mutation specifically prevents normal protein interaction with T+5.  
2.2.3 Genetic analysis of LtrA mutants at the T+5 contact site 
To further characterize the effects of mutating LtrA positions 497 through 499, the 
ability of these alanine-substituted LtrA mutants to support in vivo intron mobility was 
assessed using the E. coli two-plasmid assay. The E. coli two-plasmid assay, diagrammed 
in Figure 2.7, utilizes the CamR intron-donor plasmid pACD2X and an AmpR recipient 
plasmid pBRR-ltrB to measure the efficiency of intron mobility. The intron/IEP donor 
plasmid uses a lactose-inducible T7 promoter (PT7lac) to express an Ll.LtrB intron RNA 
with flanking 5’- and 3’-exons. A T7 promoter (PT7) is inserted in DIV of the intron near 
the 3’-end, which ultimately provides a marker for intron insertion into the recipient 
plasmid (described below). The LtrA protein is also expressed from pACD2X, 
downstream of the Ll.LtrB 3’-exon. The recipient plasmid, pBRR-ltrB, harbors a 
promoterless tetR gene downstream of the Ll.LtrB intron target site (ligated 5'- and 3'-
exons). Induction of the donor plasmid leads to expression of an Ll.LtrB precursor RNA, 
which is spliced by the LtrA protein to produce active RNPs. RNP-mediated intron 
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integration into the DNA target site of the recipient plasmid delivers the PT7 promoter and 
activates tetR expression. The mobility efficiency is quantified as the ratio of AmpR + TetR 
colonies to AmpR colonies. 
The mobility efficiency of the Ll.LtrB intron was assayed using recipient plasmids 
containing a target site orientated so that either the nascent lagging (pBRR3A-ltrB, LAG) 
or leading (pBRR3B-ltrB, LEAD) strand of replication could potentially be used as a 
primer for reverse transcription of the intron cDNA in the absence of endonuclease 
cleavage (Figure 2.8). A mobility bias towards the LEAD recipient has been used to 
discern LtrA mutations that specifically inhibit endonuclease cleavage (Zhong and 
Lambowitz 2003). As a control, the YRT LtrA mutant was also assayed in parallel. The 
previously characterized YRT LtrA mutant, which has three point mutations (Y529A, 
R531A, and T533A), is endonuclease deficient with slightly higher than wild-type RT 
activity (117%) and reduced reverse splicing activity (59%) (San Filippo and Lambowitz 
2002). The mobility frequency of YRT LtrA is greater with recipient vectors that allow 
the nascent leading strand from replication to prime reverse transcription of intron cDNA, 
indicating inhibition of bottom-strand cleavage activity which prevents En-mediated 
TPRT (Zhong and Lambowitz 2003).  
The degree of in vivo intron mobility inhibition by the Q497A, G498A, K499A, and 
QGK mutations parallels the in vitro biochemical activities found for each mutant as 
described in the previous section (Figure 2.9). The intron mobility efficiency using the 
G498A LtrA mutant (LEAD 43 ± 2%; LAG 37 ± 4%) was approximately wild type 
(LEAD 43 ± 1%; LAG 44 ± 2%), reflecting G498A LtrA's relatively high in vitro reverse 
splicing activity with only slightly diminished endonuclease cleavage activity. Q497A 
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LtrA supported slightly lower mobility than wild-type LtrA (LEAD 32 ± 2%; LAG 29 ± 
1%), also in line with the in vitro biochemistry data. The mobility efficiencies using 
K499A LtrA (LEAD 23 ± 1%; LAG 21 ± 1 %) and QGK LtrA (LEAD 31 ± 1 %; LAG 
24 ± 1%) were also significantly lower than wild-type LtrA, mirroring the trend of the in 
vitro biochemical data. In agreement with previous results (San Filippo and Lambowitz 
2002; Zhong and Lambowitz 2003), the mobility efficiency using YRT LtrA, which is 
much lower than that of wild-type LtrA with either recipient plasmid, was strongly biased 
towards the LEAD recipient (LEAD 0.7 ± 0.09%; LAG 0.3 ± 0.02). 
Although none of the alanine substitutions at LtrA positions 497 through 499 
produced a pronounced LEAD replication orientation bias in intron mobility, intron 
mobility with these LtrA mutants compares favorably to the in vitro biochemistry results. 
These data indicate that the inhibition of bottom-strand cleavage by the Q497A, K499A, 
and QGK mutations may be due to effects on protein structure that inhibit both reverse 
splicing and DNA endonuclease activity. The data also indicate that the increase in 
reverse splicing activity of G498A LtrA is enough to overcome its slightly reduced 
endonuclease cleavage activity to give a wild-type level of in vivo mobility.  As implied 
by the in vitro biochemical data, the Q497A, G498A, K499A and QGK mutations only 
partially disrupt the T+5 interaction so that the endonuclease activity of the these mutants 
is not inhibited enough to observe the pronounced LEAD replication orientation bias in 
intron mobility. In contrast to the G498A LtrA mutant, YRT LtrA mutant phenotype does 
not completely match the expected phenotype for an LtrA mutant that does not recognize 
T+5 (San Filippo and Lambowitz 2002; Zhong and Lambowitz 2003). Lack of T+5 
recognition is expected to both stimulate reverse splicing and inhibit bottom-strand 
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cleavage, as demonstrated when intron mobility with wild-type LtrA was assayed using 
T+5 mutant target sites (Mohr et al. 2000).  
2.3 THE T-23 CONTACT SITE      
2.3.1 Identification of the T-23 contact site 
To identify the LtrA site of interaction with T-23 in the DNA target site, the protein 
was photo-cross-linked to a DNA substrate containing the 4-S-dT substitution at the -23 
position, in the same manner described for T+5. Figure 2.10 shows the full negative-ion 
mode LC-ESI-ITMS of the cross-link-enriched tryptic-digest of the 4-S-dT-23-peptide 
cross-link. The spectrum shows a doubly-charged peak at 522 m/z (singly-charged m/z = 
1045) corresponding to the peptide NTLENR, LtrA amino acid positions 532-537, with 
the 4-S-dT adduct mass addition (Figure 2.10, inset). This sequence is found in the 
conserved putative !-helix of the LtrA DNA-binding domain (Figure 2.1) (Blocker et al. 
2005). This cross-linked peptide required further separation from non-cross-linked 
peptide background and other contaminants by in-line RP-HPLC following TiO2-affinity 
enrichment for MS detection, which enhanced the relative signal of the cross-linked 
species.  
A species resulting from " fragmentation of the backbone, which is dependent on the 
asparagine side chain (N536), is observed in the tandem mass spectrum (Figure 2.11) 
(Bowie et al. 2002). Phosphate loss from fragments containing the 4-S-dT adduct also 
occurs (Lenz et al. 2007), but the low-mass limit of this spectrum does not allow 
detection of the deoxyribose monophosphate species itself, which is the glycosidic bond 
cleavage fragment as seen in Figure 2.3 for the T+5 cross-link. Fragments resulting from 
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signature neutral losses from the side chains of asparagine, threonine, leucine, glutamic 
acid and arginine indicate the presence of these amino acids, but not their sequence order 
(Figure 2.11) (Waugh et al. 1990; Waugh et al. 1991; Waugh et al. 1993; Bowie et al. 
2002). The mass of the fragment resulting from the threonine side-chain loss indicates 
that the cross-link is formed between the side-chain hydroxyl of T533 and the 4-S-dT 
residue (Waugh et al. 1990).  
2.3.2 Biochemical activity of LtrA mutants at the T-23 contact site 
 To confirm the T-23 contact, LtrA variants containing single alanine substitutions 
for each amino acid residue from N532 through R537 in the cross-linked peptide were 
constructed as described above for the Q497-K499 peptide. With the exception of L534A 
LtrA, the single alanine substitutions at positions N532 through R538 caused the protein 
to express poorly. The RT activity of these purified alanine-substituted mutants, again 
with the exception of L534A LtrA, assayed with the artificial template-primer substrate 
poly(rA)/oligo(dT)45, as described above, was also inhibited (Figure 2.12). Not 
surprisingly, all of the RT-inactive mutants were inactive in the reverse splicing and 
endonuclease cleavage assays as well (Figure 2.13). Because these alanine substitutions 
in the DNA-binding domain of LtrA lead to inhibition of RT activity, which is primarily 
dependent on the RT and X domains, they presumably disrupt global protein structure. 
Therefore, it cannot be determined from these biochemical data whether the N532A, 
T533A, E535A, N536A and R537A mutations specifically disrupt recognition of T-23 in 
the DNA target site. The L534A mutation may also affect global LtrA structure but the 
disruption of the tertiary structure of the L534A LtrA mutant is apparently less severe 
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compared to that of the neighboring alanine-substitution mutants based on their relative 
RT activities (Figure 2.12). 
 Interestingly, the partial reverse splicing activity of L534A LtrA was significantly 
decreased (27 ± 5% of wild type), but full reverse splicing undiminished (99 ± 6% of 
wild type) (Figure 2.13). Additionally, endonuclease activity was severely inhibited by 
the L534A mutation (11 ± 1% of wild type), which is not expected for a mutant that 
supports reverse splicing at wild-type levels and makes normal contacts in the 3'-exon. 
The L534A mutation may affect binding of the DNA target site in a way that alters the 
kinetics of reverse splicing and later steps of the mobility reaction. The effects on reverse 
splicing and endonuclease cleavage could be either in addition to, or because of, changes 
in the recognition of T-23. Initial target site recognition, which is dependent on the T-23 
contact, leads directly to the first step of reverse splicing. Because the amount of the 
partially reverse spliced intermediate is reduced compared to wild-type LtrA, the 
accumulation of the fully reverse spliced intermediate suggests that the reversibility of 
the first transesterification reaction of reverse splicing is affected by the L534A mutation. 
The slightly altered tertiary structure of L534A LtrA may indirectly disrupt protein 
contacts with the 3'-exon by positioning the bound DNA target site in way that prevents 
other sites in the protein from interacting with T+5 or the bottom-strand cleavage site.  
2.3.3 Genetic analysis of LtrA mutants at the T-23 recognition site 
Although L534A was the only active mutant from the conserved #-helical region that 
expressed and purified normally, results from LtrA unigenic evolution experiments 
implied that these mutants may be active in the in vivo mobility assay when expressed 
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simultaneously with Ll.LtrB intron RNA (San Filippo 2003). Mutations that affect 
protein recognition of T-23 in the DNA target site are not expected to lead to any 
replication orientation bias in mobility frequency. However, the YRT LtrA mutant 
(discussed in detail in Section 2.2.3) partially overlaps with the conserved #-helical 
region and does show a replication orientation bias in the mobility assay. Therefore, the 
N532-R537 alanine-substituted LtrA mutants were also tested for the bias in mobility.  
The single alanine substitutions at positions N532 through R537 strongly inhibit 
intron mobility (Figure 2.14). The intron mobility efficiency with the N532A LtrA 
mutant was particularly low (LEAD 0.52 ± 0.07%, LAG 0.08 ± 0.03%). Alanine 
substitutions at the other positions inhibited intron mobility less severely but were still 
uniformly low (T533A: LEAD 12 ± 1%,  LAG 22 ± 1%; L534A: LEAD 10 ± 0.2%, LAG 
9 ± 1%; E535A: LEAD 12 ± 0.3%, LAG 12 ± 1%; N536A: LEAD 17 ± 1%, LAG 23 ± 
1%; R537A: LEAD 16 ± 6%, LAG 6 ± 1%). Taken together with the in vitro biochemical 
data, these findings suggest that single alanine substitutions at positions N532, T533, 
E535, N536, and R537 disrupt protein tertiary structure but this effect can be at least 
partially overcome by the presence of the Ll.LtrB intron RNA as the protein is translated 
and folds in vivo. Some fraction of L534A LtrA is capable of folding properly without 
co-expression of the Ll.LtrB intron RNA based on its combination of higher in vitro 
biochemical activity with similar in vivo mobility efficiency as the other N532-R537 
alanine-substituted mutants. 
Interestingly, the N532A and R537A LtrA mutants produced a leading strand 
mobility bias. Because such a mobility bias reflects a specific inhibition of bottom-strand 
cleavage but not reverse splicing, this phenotype is unexpected for mutations near the site 
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of T-23 recognition. This may be caused by the disruption of the protein's normal tertiary 
interactions, which were also implicated in the in vitro biochemical analysis. These 
mutations could also directly alter protein binding to the DNA substrate to allow reverse 
splicing but inhibit bottom-strand cleavage by mispositioning the 3'-exon relative to the 
En domain. A scenario where both disrupted protein tertiary structure and direct effects 
on DNA substrate binding contribute to the observed phenotype is also possible.  
2.3.4 T-23 to G-23 specificity switch  
The same partially-randomized libraries used for the mutagenic evolution 
experiments (see Section 2.3.1) were tested against DNA target sites with mutant -23 or -
21 positions to identify potential specificity switch LtrA variants. This screening 
identified two variants with higher mobility efficiencies against the T-23G target site 
compared to the wild-type target site. Both LtrA variants contained the mutation L534H 
(one also contained an additional mutation, N532T), and two other variants with mobility 
efficiencies similar to wild-type LtrA with the T-23G target site contained the mutation 
L534H along with other mutations (San Filippo 2003).  
Based on these findings, I constructed an LtrA variant with the point mutation 
L534H, and carried out genetic assays comparing the mobility efficiencies of wild-type 
LtrA and L534H LtrA with -23 position mutant DNA target sites (Figure 2.15). In 
agreement with previous results, the wild-type LtrA protein showed a strong preference 
for the wild-type DNA target site containing T-23 and decreased mobility frequencies 
with the three mutant target sites (30-50% relative to wild-type target site) (Zhong et al. 
2003). By contrast, L534H LtrA showed a marked specificity switch, with a preference 
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for T-23G (49 ± 3% relative to wild-type LtrA with wild-type target site) compared to the 
wild-type or other mutant target sites (20-30% relative to wild-type LtrA with wild-type 
target site).  
2.4 DISCUSSION 
2.4.1 Functionally important regions of the DNA-binding domain 
Multiple sequence alignments of the LtrA C-terminal domains with those of related 
group II IEPs show little sequence conservation within the DNA-binding domain (San 
Filippo and Lambowitz 2002; Blocker et al. 2005). However, two functionally important 
regions were identified and confirmed by unigenic evolution analysis, a high-throughput 
genetic method in which functional variants are isolated from a library of mutant proteins 
with random PCR-induced mutations (San Filippo and Lambowitz 2002). One of these 
regions is near the beginning of the DNA-binding domain and contains a small cluster of 
basic amino acid residues. The other is near the N-terminus of the domain and contains a 
predicted #-helix, which was conserved in all functional variants (Figure 2.1). Despite 
minimal sequence homology, both of these regions have been identified in the DNA-
binding domains of related group II intron IEPs.  
2.4.2 T+5 recognition 
My MS results map a T+5 contact site to the peptide QGK (positions 497-499) in the 
LtrA DNA-binding domain. The collision induced fragmentation pattern indicates that 
the cross-linked amino acid residue is G498 or K499. Biochemical experiments 
confirmed that alanine substitutions at G498 or K499 virtually abolish cross-linking to 4-
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S-dT+5, and both mutations inhibit DNA endonuclease activity. The Q497A mutation 
has little effect overall. Moreover, the G498A substitution creates the same distinctive 
phenotypic pattern as a T+5 mutation, inhibiting bottom-strand cleavage but stimulating 
reverse splicing (Mohr et al. 2000). This finding strongly suggests that G498 is involved 
in recognition of T+5, while K499 may strengthen the contact.  
The simplicity of glycine provides for limited routes of interaction with the thymine 
base. In some cases, the hydrogen of the peptide nitrogen can form a hydrogen bond with 
the thymine O2, though this provides no strict sequence specificity because any base 
provides an H bond acceptor at roughly the same position (Treiber et al. 2010). A more 
likely scenario for the glycine-T+5 base interaction is through the #-carbon and side-
chain hydrogen, which can pack closely with the thymine C5 methyl group through 
hydrophobic interactions, as seen in the helix-turn-helix (HTH) motif of the lambda 
repressor bound to its operator sequence (Jordan and Pabo 1988). This potential mode of 
interaction is supported by deoxyuracil substitution and KMnO4 modification interference 
data that point to features of T+5 on the major groove side of the base, particularly the C5 
methyl group, as important determinants for recognition by LtrA.  
Curiously, while G498 is strongly selected in active LtrA variants, the two flanking 
residues Q497 and K499 are the most variable in the basic cluster region (San Filippo 
2003). The function of the neighboring residues in the basic cluster is unclear. Previous 
work analyzed the effect of mutations at R501, R502, and Y503 (San Filippo and 
Lambowitz 2002).  This work showed that mutating R501, R502, and Y503 all to 
alanines (the RRY mutant) inhibits both reverse splicing and bottom-strand cleavage 
activity. The R501A and R502A single mutations also inhibit both reverse splicing and 
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bottom-strand cleavage. However, the reverse splicing and bottom-strand cleavage of 
Y503A LtrA are at near wild-type levels. Of the four, only R502A LtrA retains near 
wild-type RT activity (83%). This pattern suggests that these amino acids may contribute 
to DNA binding through some partially redundant interactions which help coordinate the 
LtrA En and RT domains for bottom-strand cleavage and initiation of TPRT, 
respectively, or they may be involved in the LtrA conformational changes required for 
transfering the DNA cleavage site to the RT active site to initiate TPRT following 
endonuclease cleavage as discussed in Section 3.3 (San Filippo and Lambowitz 2002; 
Noah et al. 2006). The T+5 contact and basic cluster may help anchor the En domain in 
the correct position to cleave between positions +9 and +10. 
2.4.3 T-23 recognition 
Protein recognition of T-23 is thought to occur early in the intron mobility reaction 
and is required for reverse splicing. Deoxyuracil substitution and KMnO4 modification 
data also indicate that LtrA contacts T-23 in the major groove through the C5 methyl 
group (Singh and Lambowitz 2001). Here, I have identified a predicted #-helix, spanning 
the peptide NTLENR in the LtrA DNA-binding domain, responsible for making the T-23 
contact. Protein #-helices often make base-specific contacts through the DNA major 
groove (Church et al. 1977; Luscombe and Thornton 2002). The geometry of the major 
groove accommodates #-helices in multiple orientations which allows for a wide variety 
of potential interactions (Pabo and Sauer 1992). This putative #-helix (N532A-K539) is 
long enough, at approximately 12 Å, to make contact with additional nearby positions in 
the distal 5'-exon of the DNA target site found to be important for sequence recognition, 
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such as G-21 or A-20, or with sites on the phosphate backbone of either the top or bottom 
strand.  
Using the cross-linking, biochemical and genetic data presented here, a model of the 
interactions between this #-helix and the DNA target site has been created by hand 
docking an idealized #-helix encompassing this peptide onto the B-form DNA substrate 
(Figure 2.16). Based on the nature of the 4-S-dT-23-peptide cross-link, the hydrogen of 
the T533 side-chain hydroxyl is in position to interact with O4 carbonyl of the thymine 
base. The mutational analysis and specificity switch genetic data imply that the 
neighboring residue, L534, may also be involved in recognition of T-23.  Multiple 
orientations of the #-helix could allow for the T533-T-23 interaction, but only one 
potential orientation also places the hydrophobic L534 side-chain near the thymine C5 
methyl group. In this same orientation R537 and K539 are positioned to contact the 
phosphate backbone at positions -24 in the top strand and -19 in the bottom strand, 
respectively, which have both been indicated as sites of contact by ethylation interference 
data (Singh and Lambowitz 2001). Additionally, the E535 side-chain is positioned to 
potentially interact with either G-21 or A-20, depending on the specific side-chain 
rotamer as it exists in the actual #-helical structure. Recognition of guanosine or 
adenosine bases by glutamic acid has been shown to occur through direct hydrogen 
bonding or indirect water-mediated bonding (Luscombe et al. 2001), either of which is 
possible in this model. 
This model also provides a potential explanation for the L534H LtrA specificity 
switch to T-23G (Figure 2.17). Substitution of L534 with histidine sterically prevents the 
same T533 interaction with a thymine base at the -23 DNA position, even if the #-helix is 
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reoriented to account for the larger histidine side-chain. Furthermore, slightly rotating the 
#-helix brings the histidine side chain into close enough proximity to the guanine base at 
the -23 position to interact through hydrogen bonding, the typical mode of interaction for 
histidine and guanine (Garvie and Wolberger 2001; Luscombe et al. 2001). The 
reoriented #-helix is also still positioned to allow the other potential contacts described 
above, but with less ideal geometries. This may explain the generally reduced mobility 
efficiency of the L534H mutant compared to wild-type LtrA.       
2.4.4  Analysis of DNA-binding domain site LtrA mutants 
Previously, the substitution of Y529, R531, and T533 all with alanines (the YRT 
mutant) was found to inhibit reverse splicing and even more strongly inhibit bottom-
strand cleavage, with Y529A the most critical of the three mutations. R531A LtrA retains 
high RT activity with only somewhat reduced reverse splicing and bottom-strand 
cleavage activity. T533A LtrA had wild-type levels of both activities in the previous 
study, however, here I find that T533A LtrA is virtually inactive in RT, reverse splicing 
and bottom-strand cleavage assays. This contradiction may be due to differences in the 
purification methods used to isolate the recombinant LtrA proteins. The current method 
includes a polyethylenimine (PEI) precipitation to remove cellular nucleic acid non-
specifically bound to LtrA that would be carried through the purification process. 
Previously, PEI precipitation was not used to remove nucleic acid.  
Unlike G498A LtrA, YRT LtrA did not show stimulation of reverse splicing activity 
in concert with decreased bottom-strand cleavage activity. The conclusion was that the 
pattern of inhibition for YRT LtrA was consistent with a disruption of interactions that 
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contribute to both reverse splicing and bottom-strand cleavage. The stronger inhibition of 
bottom-strand cleavage by these mutations could reflect more severe disruption of 3’-
exon interactions that are required specifically for bottom-strand cleavage or disruption 
of interactions with the 5’-exon which result in an altered orientation of the En domain 
that prevents bottom-strand cleavage.  
This idea is supported by the reverse splicing and bottom-strand cleavage data for 
alanine substitution at the nearby L534 position. Partial reverse splicing and bottom-
strand cleavage are both inhibited by the L534A mutation. However, the apparent level of 
full reverse splicing, the reaction step between partial reverse splicing and bottom-strand 
cleavage, is at wild-type levels. This finding raises the possibility that the positioning of 
the 5'-exon upon initial recognition is affected by the mutation and this altered binding 
affects the equilibrium between the partial and full reverse splicing intermediates and 
downstream endonuclease cleavage. Additionally, the mobility efficiencies of the N532A 
and R537A LtrA mutants display a replication orientation bias towards the LEAD 
recipient, indicating a specific inhibition of bottom-strand cleavage. This unexpected 
phenotype for mutants so close to the site of T-23 contact at residue T533, underscores 
the role that amino acid residues near the contact sites in the DNA-binding domain play 
in orienting other specific protein domains correctly with respect to the DNA substrate 
for all phases of the retrohoming reaction pathway. 
Although I demonstrate that G498/K499 and T533 interact directly with the DNA 
target site, other nearby amino acid residues may be involved in direct or indirect 
interactions with the En or RT domains. DNA-binding domain mutations are known to 
affect RT activity of group II intron IEPs (San Filippo and Lambowitz 2002). YRT LtrA 
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has slightly higher than wild-type RT activity, as does the yeast aI2 IEP mutant P714T, 
which contains a similarly placed point mutation in the analogous predicted #-helix 
(Zimmerly et al. 1995b). The RT activity of Y529A LtrA and R531A LtrA is stimulated 
to an even greater degree (169% and 157% of wild type, respectively) (San Filippo and 
Lambowitz 2002). Conversely, deletion of the En domain essentially abolishes RT 
activity, while En domain point mutations at conserved amino acid positions are, to 
varying degrees, inhibitory (San Filippo and Lambowitz 2002). These effects could be 
due to the disruption or strengthening of direct interactions between the domains of the 
IEP or caused by altered positioning of the DNA during the mobility reaction and 
initiation of reverse transcription. 
2.4.5 Specificity switch LtrA mutants 
 The identification of specific amino acid residues in the LtrA protein that interact 
with important features of the DNA target site during retrohoming may have practical 
applications in gene targeting. Although LtrA recognition of specific DNA target site 
positions is flexible enough to identify multiple target sites in most genes, the range of 
target sites and the mobility efficiency at some potential target sites is certainly limited by 
these fixed protein interactions (Perutka et al. 2004).   
 Here, I have identified the site of interaction with T-23 in the DNA target site as 
LtrA amino acid residue T533. Previously, the L534H mutation at the neighboring 
residue was identified as causing a specificity switch to T-23G. However, as 
demonstrated here, the degree of specificity for G-23 by L534H LtrA is not as great as 
that of wild-type LtrA for the wild-type (T-23) DNA target (Figure 2.15), which suggests 
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potential room for improvement. Mutations that compensate for the altered orientation of 
the conserved #-helix with the L534H mutation may make it possible to increase both the 
specificity for T-23G and the overall retrohoming efficiency. 
 No similar LtrA specificity switch mutant for T+5 has been identified thus far. 
Now that G498 has been identified as the T+5 LtrA interaction site, work has begun in 
this direction. Even if the selectivity for a specific nucleotide residue at -23 or +5 of an 
LtrA mutant is not such to make it a true specificity switch, simply relaxing the targeting 
rules at these positions may also be useful. More flexible recognition at these DNA 
positions by the IEP simplifies the task of identifying potential target sites and may 
increase the number of possible target sites within a targeted gene. 
2.5 METHODS 
2.5.1 Recombinant plasmids and mutant LtrA constructs 
pACD2, the intron donor plasmid used for genetic assays, contains a 940–nt 
Ll.LtrB–"ORF intron with a T7 promoter inserted in intron domain IV (Guo et al. 2000; 
Karberg et al. 2001). The intron and flanking exons are cloned downstream of an IPTG–
inducible T7lac promoter in a CamR pACYC184–derivative, with the LtrA protein 
expressed from a position downstream of the 3'-exon. pACD2X is a derivative of pACD2 
that contains an XhoI site inserted 8-bp downstream of the LtrA ORF termination codon 
to facilitate introduction of mutations (San Filippo and Lambowitz 2002). 
pBRR3–ltrB, the recipient plasmid used for genetic assays, contains a minimal 
Ll.LtrB intron target site (ligated ltrB gene E1–E2 sequence extending from positions –30 
to +15 from the intron–insertion site) cloned upstream of a promoterless tetR gene in an 
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AmpR pBR322–derivative (Guo et al. 2000; Karberg et al. 2001). Recipient plasmids 
containing mutant target sites were constructed by synthesizing complementary DNA 
oligonucleotides that correspond to the modified DNA target sequence flanked by AatII 
and EcoRI sites. The annealed DNA oligonucleotides were digested with AatII plus 
EcoRI and cloned between the corresponding sites of similarly digested pBRR3–ltrB, 
which had been treated with calf intestinal alkaline phosphatase (CI–AP) (Invitrogen, 
Carlsbad, CA). 
Alanine-substituted LtrA mutants for in vitro use were created by generating double-
stranded DNA inserts containing GCA codon(s) substituted in-frame into the LtrA ORF 
by two-step, overlapping PCR using pImp-1P as template (Saldanha et al. 1999). The 
inserts were flanked by XmaI and MscI restriction sites. Full-length inserts were digested 
with XmaI and MscI and purified in a 1% agarose gel. pImp-1P was digested with XmaI 
and MscI and the fully digested vector backbone was agarose gel-purified. Full-length, 
digested inserts were ligated into the pImp-1P backbone with T4 DNA ligase (New 
England Biolabs, NEB, Ispwitch, MA) overnight at 16°C.  
Alanine-substituted LtrA mutant ORFs were transferred from the pImp-1P-derived 
vectors to the donor plasmid pACD2X for in vivo use. The segment of the LtrA ORFs 
containing the alanine or histidine substituted codon (GCA or CAT) from the pImp-1P-
derived vectors was amplified by PCR. The primers used, LtrA551F (5'- 
GAAAATGAGCCAATTGATTTATAAATTTCTAAAAG-3') and LtrA1797R (5'-
GGTGCTCGAGATATCTCACTTGTGTTTATGAATCACGTGACG-3), allow insertion 
into pACD2X between the MfeI and XhoI restriction sites. 
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2.5.2 Reconstitution of RNPs 
Ll.LtrB intron RNPs were reconstituted using purified recombinant LtrA protein and 
in vitro synthesized Ll.LtrB-"ORF lariat RNA using a modification of a previously 
described method (Saldanha et al. 1999). Wild-type LtrA protein was expressed from 
pImp-1P in E. coli BL21(DE3) grown in LB media containing 50 µg/ml ampicillin. 
pImp-1P expresses protein with a C-terminal intein-linked chitin-binding domain, which 
allows the LtrA to be purified via chitin-affinity column chromatography, using a slight 
modification of a previous protocol (Saldanha et al. 1999). Here, prior to loading the cell 
lysate to the chitin-affinity column, nucleic acid was precipitated by adding 
polyethyleneimine (PEI) dropwise to 0.1% while stirring at 4°C for 1 h, followed by 
centrifugation at 4000 X G for 30 min at 4°C (Avanti JA-I Centrifuge, JA-14 rotor, 
Beckman-Coulter, Fullerton, CA). Protein concentrations were determined by Bradford 
assay with LtrA protein whose concentration was previously determined by A280 as a 
standard. The LtrA protein preparations were >98% pure based on SDS-polyacrylamide 
gels stained with Coomassie blue. Mutant LtrA proteins were expressed and purified as 
described for wild-type LtrA.  
The 793-nucleotide Ll.LtrB-$ORF precursor RNA, consisting of the 750-nucleotide 
Ll.LtrB-$ORF intron flanked by the 25-nucleotide 5’-exon sequence and 18-nucleotide 
3’-exon sequence, was transcribed from a BamHI-linearized pDR2C plasmid template 
with phage T7 polymerase, using a MEGAscript kit (Ambion, Austin, TX). The 
transcription reaction was terminated by phenol-chloroform-isoamyl alcohol (25:24:1. 
v:v:v; phenol-CIA, Ambion) extraction. Salt and free nucleotides were removed by 
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ethanol precipitation followed by a 70% ethanol wash. Ll.LtrB-$ORF intron lariat was 
generated by self-splicing 3 nmol precursor RNA in 1 ml of 1.25 M NH4Cl, 50 mM 
MgCl2, and 40 mM Tris-HCl (pH 7.5) at 42°C. Prior to self-splicing, the precursor RNA 
was renatured in 1.25 M NH4Cl, 5 mM MgCl2, and 40 mM Tris-HCl (pH 7.5) by heating 
to 55°C and slowly cooling to 42°C. Self-splicing was initiated by adding MgCl2 to 50 
mM. The reaction mixture was incubated at 42°C for 3 h and then cooled to 30°C 
(Saldanha et al. 1999; San Filippo and Lambowitz 2002). 
RNPs were reconstituted by adding the self-spliced RNA and 9 mmol purified LtrA 
to reconstitution medium pre-heated to 30°C and adjusting to 20 ml final volume with 
concentrations of 500 mM NaCl, 25 mM NH4Cl, 5 mM MgCl2, and 50 mM Tris-HCl (pH 
7.5). The reconstitution reaction was incubated at 30°C for 90 min and the RNPs were 
isolated by ultracentrifugation in a Beckman Ti50.2 rotor (Beckman-Coulter; 40,000 rpm 
for #12 h at 4°C). The RNP pellet was resuspended in 300 µl of 10 mM MgCl2, 10 mM 
KCl, and 50 mM Tris-HCl (pH 7.5), and stored at -80°C. Final concentrations of 
resuspended RNPs ranged from 1 %g/%l to 2 %g/%l. RNPs were reconstituted with mutant 
LtrA proteins and in-vitro synthesized Ll.LtrB-"ORF lariat RNA as described above for 
wild-type RNPs. 
2.5.3 DNA substrates for cross-linking 
DNA substrates, corresponding to the wild-type Ll.LtrB intron integration target site 
from positions -30 to +15 (see Figure 1.2 for sequence), used for preparative-scale cross-
linking, were synthesized (Keck Biotechnology Resource Laboratory, Yale University, 
New Haven, CT) with site-specific substitutions of photoactive nucleotide analogues. The 
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4-S-dT+5 and 4-S-dT-23 DNA substrates contain a 4-thio-deoxythymine (4-S-dT) (Glen 
Research Corp., Sterling, VA) in place of the wild-type thymine at top strand positions 
+5 or -23, respectively.  
For the DNA substrate used for analytical-scale cross-linking, a single-stranded 
oligonucleotide, corresponding to top strand positions +5 to +15, with 4-S-dT at the +5 
position was synthesized (Keck Biotechnology Resource Laboratory, Yale University, 
New Haven, CT) and 5’-end labeled with ["-32P]ATP (PerkinElmer, Waltham, MA) 
using T4 polynucleotide kinase (NEB). The labeled oligonucleotide and an equimolar 
concentration of DNA target top strand oligonucleotide from positions -46 to +5 were 
annealed to an equimolar amount of DNA target bottom-strand oligonucleotide from 
positions -46 to +15 (Integrated DNA Technologies, Coralville, IA). The two top-strand 
oligonucleotides were then ligated with T4 DNA ligase (NEB) and phenol-CIA extracted. 
The substrate was purified in a 2% agarose gel to remove single stranded 
oligonucleotides and free nucleotides (PureLink Gel Extraction Kit, Invitrogen, Carlsbad, 
CA). 
2.5.4 Cross-linking and analysis 
For preparative-scale cross-linking of the LtrA protein to the DNA substrate, 0.5 
nmol of reconstituted RNPs and 5 nmol of DNA substrate were incubated for 15 min at 
37°C in 4.5 ml reverse-splicing buffer containing 10 mM MgCl2, 10 mM KCl, and 50 
mM Tris-HCl (pH 7.5). The reaction mixture was spotted in 50 µl aliquots onto a silane-
treated glass plate over ice for UV irradiation. The spots were irradiated over ice for 45 
min with a 365-nm UV lamp (Spectroline, Westbury, NY).  
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Following irradiation, the spots were collected and combined. CaCl2 was added to 5 
mM and the reaction mixture was incubated with micrococcal nuclease (NEB) and Turbo 
DNase (Ambion) at 37°C for 1 h. The protein was precipitated by adding four volumes of 
-20°C, 10% (w/v) trichloroacetic acid (TCA) in acetone, incubating overnight at -80°C, 
and centrifuging at 10,000 rpm for 1 h at 4°C. The pellet was washed in 300 µl -20°C 
acetone to remove residual TCA, and air-dried to remove residual acetone. 
For trypsin digestion, the pellet was resolubilized by adding 20 µl 0.2% ProteasMAX 
surfactant (Promega, Madison, WI) in 50 mM NH4HCO3 and 15 µl 8 M urea and 
vortexing on medium speed at room temperature until completely resuspended. The 
mixture was diluted to 100 µl with 50 mM NH4HCO3. The LtrA protein was then reduced 
by adding dithiothreitol (DTT) to 5 mM and incubating at 56°C for 20 min. 1 µl of 1% 
ProteasMAX surfactant in 50 mM NH4HCO3 and 1.8 µg sequencing-grade Trypsin Gold 
(Promega) were added, and the reaction was incubated overnight at 37°C. 
The mixture of peptides from the protease digest was enriched for the cross-linked 
peptide using Titansphere Phos-TiO spin columns according to the manufacturer's 
protocol (GL Sciences Inc. Tokyo, Japan) (Thingholm et al. 2006). The enriched peptide 
cross-link mixture was analyzed by electrospray-ionization (ESI) tandem mass 
spectrometry in negative-ion mode (Thermo LTQ mass spectrometer, Thermo Electron 
Corp., San Jose, CA). In samples introduced by direct infusion, a Harvard syringe pump 
(Holliston, MA) was used at a flow rate of 3 %l/min. For other samples, as indicated, in-
line reverse-phase HPLC (RP-HPLC) using a Dionex Ultimate 3000 capillary HPLC 
system (Sunnyvale, CA) with a UV detector (VWD-3100) set at 260 nm and a 300 %m x 
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15 cm Dionex Acclaim PepMap 100 C18 column, was required to separate cross-linked 
peptides from background contaminants before introduction by ESI. The ESI source was 
operated in the negative-ion mode with an electrospray voltage of 3.5 kV and a heated 
capillary temperature of 90°C.  
For analytical-scale cross-linking, the radiolabeled DNA substrate described above 
was used so that cross-linking could be qualitatively observed by the transfer of the 
radiolabel to the protein. 5 pmol of reconstituted RNPs were cross-linked with 50 pmol of 
DNA substrate containing a radiolabeled photoactive nucleotide analogue in 50 µl 
reverse-splicing buffer, Turbo DNase digested, and acetone precipitated as described 
above. The samples were resolubilized in 25 µl 1X Laemmli SDS-polyacrylamide gel 
loading buffer, heated to 95°C for 5 min, and centrifuged at 15,000 rpm for 1 min. 10 µl 
of each sample was loaded onto a 10% Tris-HCl Mini-gel (BioRad. Hercules CA) and 
run at 25 mA. The gel was soaked in isopropanol/glycerol/acetic acid (25:20:10, v/v/v) 
solution for 1 h before drying under vacuum at 80°C overnight. The dried gel was 
visualized by autoradiography. 
2.5.5 Intron mobility assays 
Intron mobility was assayed by using a genetic system in which a modified Ll.LtrB 
intron containing a phage T7 promoter inserted near its 3'-end inserts into a target site 
upstream of a promoterless tetR gene, thereby activating the expression of that gene (Guo 
et al. 2000; Karberg et al. 2001). The mobility assays used intron donor plasmid 
pACD2X encoding the Ll.LtrB-$ORF intron with wild-type or mutant LtrA proteins, and 
the recipient plasmid pBRR3–ltrB, containing wild-type or mutant Ll.LtrB intron target 
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sites, cloned upstream of the promoterless tetR gene. The donor plasmid was 
electroporated or chemically transformed into E. coli HMS174(DE3) harboring the 
recipient plasmid, and cells were grown overnight at 37°C in LB medium containing 
chloramphenicol and ampicillin. The cells were then incubated with 100 µM IPTG for 1 
h at 37°C, diluted, and plated onto LB medium containing ampicillin without or with 
tetracycline to select TetR + AmpR colonies in which the intron had inserted into the target 
site (Guo et al. 2000). Mobility efficiencies were determined as the ratio of TetR + AmpR / 
AmpR colonies. Mobility assays with site-specific amino acid variants of LtrA at DNA 
recognition sites as determined by cross-linking were carried out as described above. 
Mobility assays used to test for replication orientation bias were conducted as 
described previously (Zhong and Lambowitz 2003). The recipient plasmids, pBRR3A-
ltrB and pBRR3B-ltrB, contain the Ll.LtrB intron target site/tetR cassette cloned in 
opposite orientations relative to the direction of DNA replication. The donor plasmid was 
electroporated or chemically transformed into E. coli HMS174(DE3) harboring the 
recipient plasmid, and cells were grown overnight at 37°C in LB medium containing 
chloramphenicol and ampicillin. The cells were then incubated with 100 µM IPTG for 1 
h at 37°C,  diluted, and plated onto LB medium containing ampicillin with or without 
tetracycline to select TetR + AmpR colonies in which the intron had inserted into the target 
site (Guo et al. 2000). Mobility efficiencies were again determined as the ratio of TetR + 
AmpR / AmpR colonies. 
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2.5.6 Biochemical assays 
DNA reverse splicing and endonuclease assays were performed with an internally-
labeled 129-bp DNA substrate generated by PCR in the presence of [!-32P]dTTP (3,000 
Ci/mmol; Perkin Elmer, Waltham, MA) (San Filippo and Lambowitz 2002). The DNA 
(1.25 nM, 56,000 cpm) was incubated with RNPs (12.5 nM) at 37°C for 5 min in 20 %l of 
reverse splicing medium containing 10 mM KCl, 10 mM MgCl2, and 50 mM Tris-HCl 
(pH 7.5). The reactions were terminated by phenol-CIA extraction and ethanol 
precipitated. The products were analyzed by electrophoresis in a denaturing 6% 
polyacrylamide gel, which was dried and imaged by autoradiography. The incubation 
time of 5 min is within the linear range, which was determined by performing a time 
course DNA reverse splicing and endonuclease assay with product formation measured at 
0, 1, 5, 10 15, 20, 30, 45, 60, 120, and 360 min. 
 RT assays were performed by incubating 10 %M protein pre-heated to 30°C with 
pre-heated 10 %M poly-rA oligonucleotide (~350 nucleotide, Sigma-Aldrich, St. Louis, 
MO) pre-annealed to 10 %M 42-nucleotide deoxythymine oligonucleotide (Integrated 
DNA Technologies) in 50 %l 20 mM Tris-HCl at pH 7.5, 75 mM KCl, 10 mM MgCl2, 
and 33 nM [#-32P]dTTP (3,000 Ci/mmol; Perkin Elmer) at 30°C for 5 min. The reaction 
was stopped by adding 50 %l 0.5 M EDTA on ice. 5 %l of the reaction mixture was 
spotted onto DE81 Whatman chromatography paper (Sigma-Aldrich). The paper was 
dried and washed for 5 min in 1X saline-sodium citrate (SSC) buffer three times. The 
paper was then air-died and imaged by autoradiography. The incubation time of 5 min is 
within the linear range which was determined by performing a time course protein RT 
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assay with [#-32P]dTTP-incorporation measured at 0, 10 s, 20 s, 30 s, 1 min, 2 min, 5  




Figure 2.1: The LtrA C-terminal domains 
 
The LtrA DNA-binding (D) domain and endonuclease (En) domain primary sequence is 
shown with !-helices and "-sheets predicted by the JPred3 program 
(http://www.compbio.dundee.ac.uk/www-jpred/) indicated above the sequence. A "+" 
indicates a positively charged amino acid residue. The conserved cysteine residue motifs 
(Cys Motif) and the endonuclease motif (Endo Motif) are labeled above the sequence 
(San Filippo and Lambowitz 2002; Blocker et al. 2005). The two peptides identified by 
UV-cross-linking as DNA target site contacts are in red. The peptide QGK (amino acids 
497-499) contacts the T+5 position of the DNA target site and is located at the N-
terminus of DNA-binding domain in a cluster of positively charged amino acid residues. 
The peptide NTLENR (amino acids 532-537) contacts the T-23 position of the DNA 





Figure 2.2: Full mass spectrum of the 4-S-dT+5-LtrA cross-link digest 
 
The full negative-ion mode mass spectrum (ESI-ITMS) of the enriched 4-S-dT+5 cross-
link mixture is shown with the proposed cross-link structure inset. Detection of the 
singly-charged cross-linked peptide at 634 m/z (boxed) did not require separation from 
other background species by LC.  The cross-link bond is shown at the peptide backbone 
nitrogen of G498 for illustrative purposes.  The exact position of cannot be determined 




Figure 2.3: Tandem mass spectrum of the 4-S-dT+5-LtrA cross-link peptide 
 
The CID tandem mass spectrum (ESI-CID-ITMS/MS) of the 634 m/z precursor ion 
contains fragments expected to be detected in the negative-ion mode. Ions resulting from 
water neutral loss from the precursor (616 m/z), as well as a phosphate loss from the 
precursor (536 m/z) are indicated. The y2 fragment ion plus the mass of the 4-S-dTMP 
adduct (508 m/z) localizes the cross-link to G498 or K499.  The cross-link bond is shown 
at the backbone nitrogen of G498, but the actual cross-link could be at any atom in G498 
or K499. Because the y2 ion includes the cross-link, it is subject to phosphate loss (410 
m/z). The 4-S-dTMP fragment is also observed (330 m/z), indicating fragmentation at the 
cross-link bond. Additionally, detection of the deoxyribose monophosphate (195 m/z) 
indicates cleavage of the glycosidic bond between the deoxyribose monophosphate and 
the 4-S-dT base. 
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Figure 2.4: Analytical cross-linking with alanine-substituted LtrA (positions 497-499) 
 
RNPs containing wild-type and mutant LtrA proteins were incubated with 32P-labeled 4-
S-dT+5 DNA substrate and cross-linked with 365-nm light. Nucleic acids were then 
digested with DNase I and the protein was precipitated with acetone/TCA and analyzed 
by electrophoresis in a 0.1% SDS-7.5% polyacrylamide gel. The positions of prestained 
protein size makers (Kaleidoscope Prestained Standard, Bio-Rad)) are indicated to the 
left of the gel but the markers are not shown. LtrA is approximately 80 kDa. The Q497A 
LtrA mutant cross-links at wild-type levels. Cross-linking is significantly reduced with 





Figure 2.5: RT assays of alanine-substituted LtrA (positions 497-499) 
 
Purified wild-type and mutant LtrA proteins (10 !M) were incubated with the artificial 
template-primer substrate poly(rA)/oligo(dT)45 and polymerization of ["-32P]dTTP was 
quantified by binding to DEAE paper. Incubations were at 30°C for 5 min, which was 
confirmed to be in the linear range by time course experiments. The error bars indicate 
standard deviation for at least three experiments. The RT activity of all four mutants is at 





Figure 2.6: Reverse splicing and DNA endonuclease assays with alanine-substituted LtrA 
(positions 497-499) 
 
 (A) Ll.LtrB intron RNPs (5 µM, based on RNA A260) containing either wild-type or 
mutant LtrA proteins were incubated with a 129-bp 32P-labeled DNA oligonucleotide 
substrate containing the Ll.LtrB intron insertion site (0.5 µM) at 37°C for 5 min, which 
was confirmed to be in the linear range by time course experiments, and the products 
were ethanol precipitated, phenol-CIA extracted, and analyzed in a denaturing 10% 
polyacrylamide gel. Products are indicated to the right of the gel. "Partial RS" refers to 
the partially reverse spliced intermediate and "Full RS" refers to the fully reverse spliced 
product. (B) In the schematic, the DNA substrate is represented as a solid line with the 
intron insertion site (IS) and bottom-strand cleavage site (CS) indicated. DNA fragment 
sizes, in number of nucleotides (nt), are denoted above each fragment. The partially 
reverse spliced intermediate and fully reverse spliced product are shown with intron RNA 
represented by a dashed line. (C) The bar graphs show biochemical activities relative to 
wild-type LtrA. “Total RS” refers to the combined amount of partially and fully reverse 




Figure 2.7: The E. coli two-plasmid mobility assay 
 
The intron donor plasmid pACD2X carries a camR marker and uses a T7lac promoter 
(PT7lac) to express a 940-nt Ll.LtrB intron, flanked by the 5'-exon (E1) and 3'-exon (E2), 
with a phage T7 promoter (PT7) inserted in DIV of the intron. The LtrA protein is 
expressed from a position just downstream of the 3'-exon. The recipient plasmid pBRR-
ltrB carries an ampR marker and contains the Ll.LtrB intron target site (ligated 5'- and 3'-
exon) cloned upstream of a promoterless tetR gene. The integration of the intron into the 
target site inserts PT7  upstream of the tetR gene to activate expression, yielding AmpR + 





Figure 2.8: Schematic of recipient plasmids used for replication orientation bias mobility 
assays  
 
pBRR3B-ltrB and pBRR3A-ltrB, denoted LEAD and LAG, respectively, depending on 
whether the nascent lagging or leading DNA strands could be used as the primer for 
reverse transcription of the inserted intron RNA, contain the target site/tetR cassette 




Figure 2.9: Mobility assays with alanine-substituted LtrA (positions 497-499) 
 
Mobility assays were performed as described in Figure 2.7 using the LEAD and LAG 
recipient plasmids in Figure 2.8, with 100 !M IPTG induction at 37°C for 1 h. All bar 
graphs show mobility efficiencies, defined as the ratio (AmpR + TetR colonies) / (AmpR 
colonies),  expressed as a percentage. The left side axis is for wild-type, Q497A, G498A, 
K499A, and QGK LtrA. The right side axis is for YRT LtrA. Error bars indicate standard 





Figure 2.10: Full mass spectrum of the 4-S-dT-23-LtrA cross-link digest 
 
The full negative-ion mode mass spectrum (LC-ESI-ITMS; LC retention time = 20.5 
min) of the 4-S-dT-23 cross-link is shown with the proposed peptide cross-link structure. 





Figure 2.11: Tandem mass spectrum of the 4-S-dT+5-LtrA cross-link peptide 
 
The CID tandem mass spectrum (LC-ESI-CID-ITMS/MS) of the 1,045 m/z precursor ion 
shows the doubly-charged [M-H]2- precursor ion (522 m/z), along with the corresponding 
water neutral loss ion (504 m/z) and the phosphate loss ion (424 m/z). The phosphate loss 
ion (947 m/z) of the singly-charged species is also observed. ! cleavage of the peptide 
backbone, mediated by the N536 side chain (761 m/z), is observed, but no backbone 
cleavage independent of side-chain chemistry occurs, a phenomenon that has been seen 
in previous studies of similarly sized peptides in negative-ion mode (Bowie et al. 2002). 
Peaks labeled A-D are produced by a series of side-chain eliminations, including the 4-S-
dTMP adduct, and typical neutral loss from the C- and N-termini of the precursor peptide 
(side chain or other source of loss indicated in parenthesis): peak A NH3 (N532 or N536), 
H2O (E535), H2O (C-terminus); peak B NH3 (N532 or N536), acetone-4-S-dTMP (T533); 
peak C NH3 (N532 or N536), acetone-4-S-dTMP (T533), H2O (E535), H2O (C-terminus), 
acetonitrile (R537). Peaks B and C both result from the elimination of the T533 side 
chain, however, rather than the typical neutral loss of acetone (CH3-CHO) from threonine 
(Bowie et al. 2002), the lost mass includes the entire 4-S-dTMP adduct, indicating the 
location of the cross-link bond. Peak D is the other product of the T533 side chain 




Figure 2.12: RT assays of alanine-substituted LtrA (positions 532-537) 
 
Purified wild-type and mutant LtrA proteins were incubated with the artificial template-
primer substrate poly(rA)/oligo(dT)45 and polymerization of [!-32P]dTTP was quantified 
by binding to DEAE paper. Incubations were at 30°C for 5 min, which was confirmed to 
be in the linear range by time course experiments. The error bars indicate standard 




Figure 2.13: Reverse splicing and DNA endonuclease assays with alanine-substituted 
LtrA (positions 532-537) 
 
(A) Ll.LtrB intron RNPs (5 µM) containing either wild-type or mutant LtrA proteins 
were incubated with a 129-bp 32P-labeled DNA oligonucleotide substrate (0.5 µM) 
containing the Ll.LtrB intron insertion site at 37°C for 5 min, which was confirmed to be 
in the linear range by time course experiments, and the products were analyzed on a 
denaturing 10% polyacrylamide gel. Products, as described in Figure 2.6B, are indicated 
to the right of the gel. (B) The bar graphs show biochemical activities relative to wild-
type LtrA. “Total RS” refers to the combined amount of partially and fully reverse 





Figure 2.14: Mobility assays with alanine-substituted LtrA (positions 532-537) 
 
Intron mobility assays with wild-type LtrA, or the N532A, T533A, L534A, E535A, 
N536A, or R537A mutants were performed as described in Figure 2.7, using the LEAD 
and LAG recipient plasmids described in Figure 2.8. All bar graphs show mobility 
efficiencies, defined as the ratio (AmpR + TetR colonies) / (AmpR colonies), expressed as 
a percentage. The inset graphs show the mobility efficiencies of N532A with an 




Figure 2.15: L534H LtrA specificity switch mobility assay 
 
Mobility assays were performed as described in Figure 2.7 using a series of -23 position-
mutant recipient plasmids to test for altered specificity.  The recipient plasmids contained 
either T (WT), G, C, or A residues at the -23 position of the DNA target site. The bar 
graphs show mobility efficiency relative to wild-type LtrA with wild-type (T-23) pBRR-





Figure 2.16: Model of LtrA DNA-binding domain !-helix interaction with the Ll.LtrB 
DNA target site 
 
The conserved putative !-helix (white) at the C-terminal end of the LtrA DNA-binding 
domain is shown from two different perspectives docked to the major groove of the 5'-
exon of the DNA target site. Key residues/chemical groups are highlighted. The !-helix 
is positioned to permit hydrogen bonding between the T533 side-chain hydroxyl and the 
O4 carbonyl of the thymine base at the -23 DNA position, in agreement with the DNA 
cross-linking data. The L534 side-chain is positioned to make hydrophobic contacts with 
the C5 methyl group of the thymine base, as implied by the L534H genetic switch 
mobility assay data and L534A mutational analysis. R537 and K539 are positioned to 
contact the -24 (top strand) and -19 (bottom strand) phosphate groups, respectively. E535 
could potentially contact either the G-21 or A-20 bases through hydrogen bonding or 





Figure 2.17: Model of L534H LtrA DNA-binding domain !-helix interaction with the 
Ll.LtrB T-23G mutant DNA target site 
 
The conserved putative !-helix (white) at the C-terminal end of the LtrA DNA-binding 
domain is shown from two different perspectives docked to the major groove of the 5'-
exon of the DNA target site with the T-23G mutation. Key residues/chemical groups are 
highlighted. The bulky histidine side-chain of L534H prevents T533 from contacting the 
-23 position of the DNA target site. Instead, the !-helix is slightly reoriented to 
accommodate the histidine, which hydrogen bonds to the guanine at the -23 position. 
Most other contacts described in Figure 2.16 may still be made but with imperfect 
geometries.    
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Chapter 3:  DNA bending during Ll.LtrB intron integration into DNA 
 
The complex process of group II intron retrohoming requires the IEP to contact 
specific bases in the distal 5'-exon and the 3'-exon, possibly at the same time (Mohr et al. 
2000; Singh and Lambowitz 2001). A three-dimensional homology model of the LtrA 
protein, formulated by threading the LtrA dimer onto X-ray crystal structures of the HIV-
1 RT dimer, suggests that the DNA target sequence is too long for LtrA to simultaneously 
contact both exons unless the DNA is strongly bent in the complex (Blocker et al. 2005). 
These findings raise the possibility that the propensity of a DNA sequence to bend (the 
sequence's "bendability"), in addition to the sequence requirements detailed in Section 
1.3 (Figure 1.2), might significantly influence the efficiency of integration at that DNA 
target site.  
 Here, I analyze the bending of the Ll.LtrB intron target sites by atomic force 
microscopy (AFM). The computational analysis of Ll.LtrB intron target site bendability 
by Dr. Jiri Perutka is summarized in Section 3.1. It concludes that Ll.LtrB DNA target 
sites have significantly higher predicted bendability than do random E. coli DNA 
sequences. This prefaces the collaborative work of Dr. James Noah and I, described in 
Sections 3.2 and 3.3, where AFM is used to show that the target DNA is bent at two 
progressively greater angles during the integration of group II intron RNPs, which reflect 
different stages of the retrohoming reaction pathway.  




An algorithm that used a probabilistic model based on the bendability of 
trinucleotides deduced from DNase I-digestion data (Brukner et al. 1995) calculated an 
average bendability profile for two sets of Ll.LtrB insertions sites in the E. coli genome, 
one consisting of 66 retrohoming sites used by an Ll.LtrB intron having randomized 
target-site recognition sequences (Zhong et al. 2003), and the other consisting of 33 
retrotransposition sites used by the wild-type Ll.LtrB intron (Coros et al. 2005). Both test 
sets were culled from larger sets of sites by excluding those lacking T+5, which may have 
been utilized via En-independent pathways that do not require the same IEP interactions 
with the 3’-exon, as described in Section 2.2.3 (Zhong and Lambowitz 2003; Coros et al. 
2005; Yao et al. 2005). The average bendability profiles for the tests sets were then 
compared with those for 100 different control sets, each consisting of the same number of 
randomly selected 45-bp E. coli genomic sequences (a total of 6600 and 3300 control 
sequences for the retrohoming and retrotransposition sites, respectively). A collection of 
target sites provides a better picture of bendability patterns than examination of 
individual target sites, including the wild-type site, in which the influence of bendability 
might be obscured by other features. 
 Figure 3.1 shows the bendability profiles for the retrohoming sites (red), 
retrotransposition sites (blue), the wild-type Ll.LtrB intron target site (dashed line), and 
100 control sets for the retrohoming sites (light blue). The profiles were calculated for 
positions -30 to +10, using a 6-bp sliding window and a shift increment of one. The 
control sets for the retrotransposition sites are similar to those for the retrohoming sites 
and were omitted to simplify the plots. At a 5% significance level, both the retrohoming 
and retrotransposition sites show several regions with significantly higher bendability 
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than the control sites, albeit at somewhat different locations in the retrohoming and 
retrotransposition sites (6-bp segments beginning at positions -13 to -10 and -3 in the 
retrohoming sites and at positions -20 to -18 and  -6 in the retrotransposition sites). A 
possible explanation for the different locations of the bendable regions is that the 
retrotransposition sites were obtained with the wild-type Ll.LtrB intron, while the 
retrohoming sites were obtained with an Ll.LtrB intron having randomized EBS2, EBS1, 
and ! sequences. Consequently, the retrotransposition sites are constrained to have target 
sequences that base pair with a single intron (wild-type Ll.LtrB), while the retrohoming 
sites are not similarly constrained, providing more latitude for the location of the 
bendable regions. This inference is supported by the finding that the bendability profile 
for the wild-type retrohoming site (dashed line), which must also base pair with the wild-
type Ll.LtrB intron, parallels that for the retrotransposition sites. Notably, the bendability 
peaks for the wild-type site have significantly higher amplitudes than do those in the 
profiles calculated by averaging multiple retrohoming and retrotransposition sites (see 
difference in scale on the right). These higher amplitudes may reflect the importance of 
bendability in selection of the wild-type target site. The computational analysis indicates 
that both retrohoming and retrotransposition sites have regions of higher predicted 
bendability than do random E. coli DNA sequences. Additional computational 
comparisons of protein-induced deformability (Olson et al. 1998), propeller twist (el 
Hassan and Calladine 1996), and stacking energy (Ornstein 1978) also showed significant 
differences in the retrohoming and retrotransposition sites compared to the control sets, 
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reinforcing the conclusion that Ll.LtrB integration sites may have distinctive higher-order 
structural characteristics (Noah et al. 2006). 
3.2 VISUALIZING RNP-DNA COMPLEXES BY AFM  
 Together with the HIV-1 RT-based LtrA model, the computational analysis of 
Ll.LtrB retrohoming and retrotransposition sites suggest that the bendability of DNA 
appears to be a significant factor in the suitability of DNA sequence for targeting by the 
Ll.LtrB intron RNP. In collaboration with Dr. James Noah, I used AFM to analyze 
bending of the Ll.LtrB intron DNA target site at different stages of the retrohoming 
reaction pathway using a series of mutant RNPs and altered DNA target sites. Dr. Noah 
designed the original set of DNA substrates used for the AFM experiments (Figure 3.2) 
and demonstrated their biochemical activity with Ll.LtrB intron RNPs (Figure 3.3, 
detailed description in Section 3.2.1). Additionally, he demonstrated that the RNP could 
be distinguished from the DNA substrate in Ll.LtrB RNP-DNA complexes visualized by 
AFM (Figure 3.4, detailed description in Section 3.2.2) and that the distribution of DNA 
bend angles is dependent on the incubation time prior to imaging (Figure 3.6, detailed 
description in Section 3.2.3).  
 The bulk of my contributions to this research are described in Section 3.3, but the 
imaging of free RNPs (Figure 3.5) and naked DNA substrates (Figure 3.7) discussed in 
Section 3.2 are also my work. In Section 3.3, I determined the role of IEP-DNA target 
site interactions in DNA bending at different stages of the retrohoming reaction using 
mutant RNPs and mutant or physically altered DNA target substrates. Additionally, DNA 
bending upon initiation of TPRT with the addition of dNTPs to the reaction was 
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examined. Together with previous findings, these results suggest a model in which RNPs 
bend the target DNA by maintaining initial IEP and base-pairing interactions with the 
distal 5’-exon, while engaging in subsequent interactions with the 3’-exon that 
successively position the scissile phosphate for bottom-strand cleavage at the En active 
site and then reposition the 3’-end of the cleaved bottom strand at the RT active site for 
initiation of reverse transcription. 
3.2.1 Biochemical activity with DNA target substrates 
 A series of ~240-bp wild-type Ll.LtrB DNA target site substrates and mutant 
DNA substrates with unfavorable, non-wild-type nucleotide residues in different regions 
of the Ll.LtrB intron target site were used in the AFM experiments (Figure 3.2). They 
were tested for their ability to support intron reverse splicing and bottom-strand cleavage 
(Figure 3.3). In these experiments, which are very similar to those described in Sections 
2.2.2 and 2.3.2,  wild-type Ll.LtrB RNPs were incubated with internally 32P-labeled DNA 
substrates at 37°C for 5 min or 30 min.  
 As expected, the wild-type substrate (WT) supported both full and partial reverse 
splicing, and bottom-strand cleavage. Previously, it has been demonstrated that, with 
wild-type Ll.LtrB RNPs and the wild-type target site, reverse splicing products appear 
first, while bottom-strand cleavage products appear after a lag (Singh and Lambowitz 
2001). In agreement with these findings, after 5 min, the reverse splicing products 
comprised 28% of the total radioactivity and bottom-strand cleavage products only 2%, 
while after 30 min, the reverse-splicing products comprised 52% and the bottom-strand 
cleavage products 9%. 
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 The reactions with the remaining DNA substrates were done for 30 min. The L 
DNA substrate, which contains the wild-type target site near the 5'-end of the DNA 
molecule, reacted as efficiently as the WT DNA substrate, with the shift of the site 
resulting in different sizes for the bottom-strand cleavage products (Figure 3.3). The -
30/+15 substrate, which has unfavorable non-wild-type target site nucleotide residues at 
all positions between -30 and +15, showed only a very low level of reverse splicing (< 
1% that of the WT substrate), which is likely due to inefficiently utilized cryptic target 
sites (Mohr et al. 2000). Mutant DNA substrates -30/-13 and -12/+3, which have non-
wild-type nucleotide residues in the distal 5’-exon and IBS/! regions, respectively, also 
showed <1% of the reverse splicing activity of the WT substrate and no detectable 
bottom-strand cleavage. These results are in agreement with previous findings showing 
that mutations affecting either LtrA interactions with the distal 5’-exon region or EBS-
IBS/!-!' base pairing inhibit both reverse splicing and bottom-strand cleavage (Mohr et 
al. 2000; Singh and Lambowitz 2001). 
 DNA substrate +4/+15, which has non-wild-type nucleotide residues at 3’-exon 
positions recognized by LtrA, supported efficient reverse splicing, but gave no detectable 
bottom-strand cleavage (Figure 3.3). In agreement with previous results (Matsuura et al. 
1997; San Filippo and Lambowitz 2002), Ll.LtrB intron RNPs containing a C-terminally 
truncated IEP lacking the D and En domains ("D/En LtrA) showed no detectable reverse 
splicing or bottom-strand cleavage, while Ll.LtrB intron RNPs containing a truncated IEP 
lacking only the En domain ("En LtrA) were still capable of reverse splicing, but were 
unable to carry out bottom-strand cleavage. 
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3.2.2 AFM with WT and L DNA target site substrates 
 Complexes formed between the RNPs and DNA substrates under the conditions 
of the reverse splicing and bottom-strand cleavage assays were imaged by AFM. Figure 
3.4 shows representative complexes formed after incubating wild-type Ll.LtrB RNPs 
with the WT and L DNA substrates for 30 min at 37°C. The samples were air-dried and 
imaged in tapping mode. RNP aggregation and complex immobilization in solution 
prevented RNPs from being visualized in buffer. Only well-separated complexes with 
both DNA ends visible were used for analysis. 
 In the AFM images, the RNPs appeared as a bright dot located in the center or at 
the end of the WT and L DNA substrates, respectively. The shift in the position of the 
RNPs bound to the L substrate indicates that they specifically recognized, and bound the 
DNA target sequence and also that the RNP-DNA complexes were two-dimensionally 
fixed on the aminosilane-treated mica slide in their original position in the complex. 
Based on measurements of 100 molecules, the wild-type target DNA in complex with 
RNPs had a length of 85 ± 9 nm compared to 81 ± 11 nm for the free DNA (see below) 
and a calculated length of (3.3 Å x 234 bp =) 77.2 nm. The similar lengths of free and 
bound DNA indicate that the DNA is not substantially wrapped around the RNP in the 
complex. 
 At the resolution of the AFM, the RNPs bound to the DNA substrate appear 
roughly circular. Based on measurement of 100 molecules, RNPs bound to the wild-type 
DNA substrate had a diameter of 10 ± 1 nm and a height of 0.9 ± 0.2 nm, and the 
corresponding measurements for RNPs bound to the L DNA substrate were 11 ± 2 nm 
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and 1.1 ± 0.3 nm. The RNPs bound to the L DNA substrate in Figure 3.4 were among the 
larger RNPs observed (diameters of 11 and 12 nm and heights of 1.1 and 1.4 nm). AFM 
measurements of free RNPs under the same conditions gave a diameter of 11 ± 1 nm and 
height of 1.0 ± 0.4 nm, similar to the dimensions of the RNPs bound to the DNA (Figure 
3.5). Although RNP damage caused by sample preparation or imaging cannot be 
excluded (Giro et al. 2004), only active RNPs containing both Ll.LtrB intron lariat RNA 
and the LtrA protein can react with the DNA substrate. RNA and protein by themselves 
do not bind DNA specifically (Singh and Lambowitz 2001). The relatively low height of 
the RNPs may reflect compaction by the tip, interaction of the RNPs with the mica 
substrate, dehydration, capillary forces during drying, or differences in compliance 
between the RNPs and mica substrate in tapping mode (Matsuura et al. 2006). It is 
possible that the RNPs are inherently non-globular and flattened in one dimension, with 
this flattening enhanced by dehydration, similar to the situation for E. coli small 
ribosomal subunits imaged in air (see Section 3.3)(Matsuura et al. 2006). 
3.2.3 Time-dependent distribution of bend angles in the retrohoming pathway 
 The initial AFM imaging of complexes with the WT target site, performed with 
samples incubated for 30 min at 37°C, showed that the DNA is bent around the RNPs and 
that the bend angles have a distinctly bimodal distribution with peaks at ~75° and ~90°. 
To test whether the two DNA bend angles might reflect different stages of the reactions, 
100 complexes with the WT target site after 5 and 30 min of incubation were compared 
(Figure 3.6). The lesser bend angle predominated in the 5 min samples (75 ± 6°, 83%; 88 
± 3°, 17%), while the greater bend predominated in the 30 min samples (75 ± 2°, 49%, 
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90° ± 5°, 51%). In the absence of RNPs, the same position in the WT target DNA showed 
a wide distribution of bend angles (Figure 3.7). The distribution of bend angles in the 
naked WT DNA substrate was skewed more toward larger bend angles than is the case 
for the -30/+15 mutant DNA (Figure 3.7), which possibly reflects the wild-type DNA 
target sequence's increased bendability even in the absence of RNPs (see Section 3.1). 
3.3 DNA BENDING AT DIFFERENT STAGES OF THE RETROHOMING REACTION   
3.3.1 AFM with mutant DNA target site substrates 
  As expected, complexes formed between wild-type Ll.LtrB RNPs and mutant 
DNA substrate -30/-13, which has unfavorable nucleotide residues in the distal 5’-exon 
region recognized by the IEP, or -12/+3, which has unfavorable nucleotide residues that 
disrupt EBS-IBS/!-!’ base pairing to the intron RNA, were not detected. These findings 
agree with previous DNA-footprinting experiments, which showed that DNA substrates 
having unfavorable nucleotide residues in the distal 5’-exon region do not form stable 
complexes with the RNP (Singh and Lambowitz 2001). 
 The +4/+15 mutant DNA substrate, which has unfavorable nucleotides in the 3’-
exon from position +4 to +15, could support reverse splicing, but not bottom-strand 
cleavage in the biochemical assays in Section 3.1, and, therefore, do form stable 
complexes with the RNP (Figure 3.3). Imaging of 100 complexes formed with the +4/+15 
DNA substrate showed RNPs bound at the correct position, but with a wide range of 
DNA bend angles, similar to naked DNA (Figure 3.8). These findings indicate that initial 
DNA target site recognition and reverse splicing are not by themselves sufficient to 
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induce DNA bending, and that bending requires either bottom-strand cleavage itself or 
the additional LtrA interactions with the 3’-exon that lead to bottom-strand cleavage. 
3.3.2 Imaging complexes with mutant RNPs 
 Similar conclusions were reached from AFM imaging of complexes formed with 
mutant RNPs containing C-terminally truncated LtrA proteins. RNPs reconstituted with 
the !D/En LtrA mutant, which lacks both the C-terminal DNA-binding and En domains, 
gave no detectable complexes, in agreement with DNA-footprinting experiments showing 
that these RNPs do not form stable complexes with the DNA substrate (Singh and 
Lambowitz 2001). RNPs reconstituted with the !En LtrA mutant are capable of reverse 
splicing but not second-strand cleavage (Figure 3.3). As expected, these RNPs formed 
stable complexes detected by AFM, and analysis of 100 such complexes again showed 
RNPs bound at the correct position, but with a wide distribution of bend angles (Figure 
3.8), reflecting either loss of required interactions with the 3’-exon that lead to bottom-
strand cleavage or the lack of bottom-strand cleavage itself. 
3.3.3 AFM of complexes with nicked DNA substrate 
 To distinguish whether DNA bending is caused by IEP interactions with the 3’- 
exon or by bottom-strand cleavage itself, I measured the DNA bend angles of wild-type 
RNP-bound DNA substrates with a pre-positioned nick at the bottom-strand cleavage site 
("nicked" DNA substrates) (Figure 3.9). One nicked DNA substrate contained the wild-
type DNA target sequence, and the other contained the 3’-exon +4/+15 mutations that 
block interaction with IEP. The complexes with the nicked WT DNA substrate showed 
the same two bend angles (74 ± 2°, 50% and 89 ± 2°, 50%) as those with the non-nicked 
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WT substrate, while complexes formed with the nicked +4/+15 DNA substrate still 
showed a wide distribution of bend angles (Figure 3.9). These experiments demonstrate 
that the bottom-strand nick is not by itself sufficient to cause bending and together with 
the results for the !En LtrA mutant with the wild-type DNA substrate (Figure 3.8) 
indicate that bending requires specific interactions between the IEP and 3’- exon. 
3.3.4 AFM of RNP-DNA complexes after initiation of reverse transcription 
 The addition of dNTPs during the retrohoming reaction allows LtrA to initiate 
TPRT using the cleaved bottom strand as a primer. Adding just three dNTPs (dATP, 
dTTP and dGTP) and omitting dCTP arrests reverse transcription opposite the first C-
residue in the template RNA (17 nts), which results in uniform complexes held at the 
same stage of the reaction. Complexes formed by incubating wild-type RNPs with the 
WT DNA substrate in the presence of the three dNTPs for 5 and 30 min, respectively, 
were imaged by AFM (Figure 3.10). After 5 min, the number of complexes with the two 
major bend angles was roughly equal (76 ± 3°, 48% and 90 ± 2°, 52%), whereas after 30 
min, the proportion of molecules with the greater bend angle increased dramatically (73 ± 
2°, 16% and 90 ± 4°, 84%). By contrast RNPs reconstituted with the DD- LtrA mutant, 
which have the mutation YADD"YAAA at the RT active site (Matsuura et al. 1997), 
with WT DNA after 30 min incubation under the same conditions, were predominantly 
found bent at the smaller angle (73 ± 2°, 46 %) with only a small number of complexes 
bent at the greater angle (90 ± 2°, 11%) (Figure 3.11). Together, these results suggest that 
the greater bend angle is characteristic of RNPs carrying out reverse transcription. The 
results for DD- RNPs may reflect that the integrity of the RT active site is required to 
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achieve the greater bend angle, but we cannot exclude the possibility that the mutations 
affect global protein structure. 
3.3 DISCUSSION 
 Imaging Ll.LtrB RNP-DNA substrate complexes using AFM demonstrates that 
the DNA target site is bent during the retrohoming pathway. The length of the DNA in 
the complex as determined by non-deconvoluted AFM measurements (85 ± 9 nm) is in 
good agreement with the calculated length (77.2 nm) and close to that determined by 
AFM measurements for free DNA substrate (81 ± 11 nm), indicating that the DNA is not 
wrapped around the RNPs to an appreciable extent.  
 The Ll.LtrB RNPs bound to DNA appear roughly circular with an average 
diameter of ~10 nm and a height of ~1 nm. The diameter of the Ll.LtrB RNPs (0.45 
MDa), which consist of a 0.9-kb RNA and two molecules of the 80 kDa LtrA protein 
(Saldanha et al. 1999), is in reasonable agreement with expectations for an RNP complex 
based on the E. coli small and large ribosomal subunits. The dimensions of the E. coli 
small ribosomal subunit (0.85 MDa) determined by cryoelectron microscopy or X-ray 
crystallography are 10 x 15 x 6 nm, and those for the large ribosomal subunit (1.7 MDa) 
are 24 x 24 x 15 nm (Lata et al. 1996; Ban et al. 1998; Verschoor et al. 1998; Tocilj et al. 
1999). The relatively low height measured for Ll.LtrB RNPs may reflect compaction 
during air drying/imaging or compliance differences in tapping mode between the mica 
surface and the RNP. E. coli small ribosomal subunits appear to be flattened by about 
50% by AFM imaging in air versus AFM imaging in solution (Matsuura et al. 2006).  
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 Ll.LtrB RNPs of ~10 nm diameter could potentially contact 30-bp of unbent DNA 
or >30-bp if the DNA is bent, in agreement with known distal contact points at positions -
23 and +10 (Singh and Lambowitz 2001). DNase I-footprinting, which may somewhat 
overestimate the size of the binding site, showed protection over 40-45 bp (positions -25 
to +19 on the top strand and -28 to +16 on the bottom strand) (Singh and Lambowitz 
2001). The AFM images emphasize the striking compaction of the 902-nt intron RNA in 
RNPs, which appear as a small dot on the 234-bp double-stranded DNA substrate. 
 The computational analysis showing that both retrohoming and retrotransposition 
sites have regions of higher predicted bendability than do random E. coli DNA sequences 
suggests that bendability is a significant parameter in the use of these sites. Bendability 
does not distinguish whether the RNPs preferentially recognize DNA target sites that 
were already bent or whether the flexibility of the target site increases the efficiency of 
the reaction, by decreasing the energy required to achieve the bend. AFM comparison of 
bend angles at the same position in the wild-type and -30/+15 mutant DNA substrates in 
absence of RNPs showed higher bend angles for the wild-type DNA (Figure 3.6), 
consistent with the possibility that the wild-type target site contains a higher proportion 
of molecules pre-bent at the correct positions. Assuming that the DNA on the surface 
represents a snapshot of the state of DNA bending in solution, these AFM results agree 
with recent simulations of the in-plane bending of short semiflexible polymers 
(Lattananzi 2004). While polymers with a ratio (“t”) of contour length to persistence 
length of about two (t ! 2) can only probe bend angles up to 90° with significant 
probability, more flexible polymers that have reduced persistence lengths probe larger 
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bend angles. Given that the persistence length of DNA is generally 40-45 nm or about 
half the length of these DNA substrate molecules, the distribution of bend angles in the -
30/+15 DNA show the predicted behavior for t = 2, while the wild-type DNA shows the 
behavior expected for t > 2 or much reduced stiffness (Wang et al. 1997). 
 Both the retrohoming and retrotransposition sites contain only a small number of 
nucleotide residues whose bases are recognized directly by the IEP, and with the 
exception of T+5, these are only moderately conserved in different sites (e.g., T-23, 41%; 
G-21, 79%; and A-20, 61% in the 66 retrohoming sites, and T-23, 15%; G-21, 48%; and 
A-20, 33% in the retrotransposition sites) (Zhong et al. 2003; Coros et al. 2005). The 
region of the retrohoming sites recognized by base pairing of the intron RNA also has 
variable sequences, due to the method by which the sites were selected (i.e., with an 
Ll.LtrB intron having randomized EBS2, EBS1, and ! sequences). Thus, it seems likely 
that bendability itself is a factor in the selection of Ll.LtrB intron target sites, beyond the 
nucleotide residues recognized directly by Ll.LtrB RNPs. 
 Figure 3.12 summarizes these AFM results in the form of a model showing the 
degree of bending at different stages of the reaction. First, initial DNA target site 
recognition and reverse splicing do not by themselves lead to DNA bending. A mutant 
DNA substrate with alterations between 3’-exon positions +4 and +15 (+4/+15), and 
RNPs reconstituted with mutant LtrA that lacks the En domain carry out these initial 
steps with relatively high efficiency, but are unable to carry out bottom-strand cleavage. 
In both cases, AFM imaging shows complexes with RNPs bound at the correct position, 
but with a wide distribution of DNA bend angles, similar to naked DNA. 
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 Second, DNA bending likely results from the force generated by RNPs binding 
simultaneously to both the 5’- and 3’-exon regions of the DNA target site. Previous 
studies showed that all mutations or chemical modifications in the distal 5’-exon or IBS/! 
region of the DNA target site that affect LtrA interactions or base pairing of the intron 
RNA inhibit not only reverse splicing, but also bottom-strand cleavage (Mohr et al. 2000; 
Singh and Lambowitz 2001). Although we cannot exclude that some 5’-exon interactions 
are weakened or lost at later stages, a likely interpretation is that most if not all of the 
initial RNP interactions with the distal 5’-exon are required along with 3’-exon 
interactions to position LtrA En domain for bottom-strand cleavage. Our experiments 
with nicked DNA substrates confirm that bending results from RNP interactions with the 
3’-exon and not from bottom-strand cleavage itself (Figure 3.8). As indicated previously, 
three-dimensional modeling predicted that LtrA could not interact simultaneously with its 
target sequences in the distal 5’-exon and the 3’-exon unless the DNA is bent strongly in 
the complex (Blocker et al. 2005). 
 The two progressively greater bend angles seen in time-course experiments 
presumably reflect sequential LtrA interactions that are known to occur with the 3’-exon. 
These are recognition of T+5 and 3'-exon positions for bottom-strand cleavage, binding 
of the scissile phosphate between 3’-exon positions +9 and +10 at the En active site, and 
finally, repositioning of the 3’-end of the cleaved bottom strand at the RT active site. The 
latter is expected to require a significant conformational change in the complex. We find 
that the proportion of complexes containing the greater bend angle increases after 
initiation of reverse transcription by wild-type Ll.LtrB RNPs, but decreases for 
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complexes formed with RNPs reconstituted with the DD- LtrA mutant, which have a 
mutation in the RT active site (Figure 3.9). X-ray crystal structures of retroviral RTs with 
bound template-primer substrates typically show a 40° bend in the template strand near 
the polymerase active site (Ding et al. 1998; Cote et al. 2000; Sarafianos et al. 2001) and 
even greater bend angles are seen for other polymerases (E. coli RNA polymerase, 90° 
and human DNA polymerase !, 90°) (Maitra et al. 2002). The DNA bend angle observed 
here for reverse transcribing RNPs may reflect not only an analogous bend at the RT 
active site, but also that the RNPs maintain contacts involved in DNA target site 
recognition during the initial stages of reverse transcription. At present, one can only 
imagine the acrobatics required to progressively unwind the highly folded intron RNA 
through the RT active site, a process that presumably requires disruption of the strong 
LtrA interactions that stabilized the folded intron RNA structure for RNA splicing and 
reverse splicing, as well as LtrA and intron RNA contacts with the DNA target site. 
3.4 METHODS 
3.4.1 DNA substrates  
DNA substrates used for biochemical assays and AFM experiments were generated 
by PCR of pLHS, which contains a 70-nt sequence of ligated ltrB exons 1 and 2, 
extending from 35-nt upstream to 35-nt downstream of the intron-insertion site (positions 
-35 to +35), cloned between the BamHI and EcoRI sites of pBSKS+ (Agilent 
Technologies, Santa Clara, CA) (Matsuura et al. 1997). 
To generate the wild-type DNA substrate, the PCR was carried out with primers 
SK+113 (5’-CCCTCACTAAAGGGAACAAAAAGC) and KS-121 (5’- 
CGACGGCCAGTGAATTGTAATAGC). The resulting 234-bp double-stranded DNA 
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contains the 45-bp E1-E2 target sequence flanked by 5’- and 3’-sequences of 91 and 98 
bp, respectively. Target site L (240 bp) contains the 45-bp Ll.LtrB intron target sequence 
at one end of the DNA oligonucleotide (positions 6-50) and was generated by PCR of 
pLHS with primers KS-35 (5’-CTTGCAACCCACGTCGATCGTG) and SK+205 (5’-
CTTCCGGCTCGTATGTTGTGTGG). Mutant DNA substrates (234 bp) contain 
unfavorable non-wild-type nucleotide residues at target-site positions -30 to -13, -12 to 
+3, +4 to +15, and -30 to +15, respectively. The non-wild-type residues are those 
occurring at lowest frequency at each position in the set of retrohoming sites in the E. coli 
genome obtained with an Ll.LtrB intron with randomized target-site recognition 
sequences (Zhong et al. 2003). These mutant target DNAs were generated via two PCR 
steps. In the first step, two separate PCR reactions were done with outside primers 
SK+113 or KS-121 and overlapping internal primers, containing the DNA target site 
mutations. The internal primers were: SK-30/-13 (5’- 
GTAAGATAATGGTCCTGACACATCCATAACCATATC) 
and KS-30/-13 (5’- TGTGTCAGGACCATTATCTTACTGCAATTATCCACTAG);  
SK -12/+3 (5’-TCGTGACTGAAGGTAAAAAATGATCATTTTTAATTCTACG) and  
KS -12/+3 (5’-CATTTTTTACCTTCAGTCACGATCGACGTGGGTTG);  
SK +4/+15 (5’- CGGCAATATATGTCTACGAATCTTTATACTGG) and KS +4/+15 
(5’- CGTAGACATATATTGCCGATGGTTATGGATGTGTTCACGA); and SK -
30/+15  
(5’ -TTTTTACCTTCAGCAGGACCATTATCTTACTGCAAGGATCCACTAG) and 
KS -30/+15 (5’-
GGTCCTGCTGAAGGTAAAAAATGCGGCAATATATGTCTACGAATCTTTATAC
TGGG). The products of the first PCR were gel-purified, mixed, and used in a second 
PCR with the outside primers to yield 234-bp DNA substrates containing the desired 
modifications. 
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To generate wild-type and mutant +4/+15 DNA substrates containing a nick at the 
bottom-strand cleavage site, the top strand was amplified by unidirectional PCR of pLHS 
or the gel-purified +4/+15 DNA substrate, respectively, with primer KS-121 (see above). 
After extraction with phenol-CIA, the unidirectional PCR products were annealed with a 
ten-fold molar excess of complementary gel-purified bottom-strand oligonucleotides (129 
and 105 nts) by heating to 90°C for 5 min and then slowly cooling to room temperature. 
The resulting 234-bp double-stranded DNAs with a nick at the bottom-strand cleavage 
site were purified in a 1% agarose gel. 
3.4.2 Reconstitution of RNPs 
Ll.LtrB RNPs were reconstituted with purified LtrA protein and in vitro synthesized 
Ll.LtrB-!ORF lariat RNA. Wild-type and mutant LtrA proteins were expressed in E. coli 
BL21(DE3), by using the intein-based expression plasmid pImp-1P, and purified as 
described in Saldanha et al. (1999). The LtrA mutant DD- has the conserved amino acid 
residues YADD in the RT active site changed to YAAA (Matsuura et al. 1997), and 
mutants !En and !D/En have C-terminal truncations at amino acid residues 547 and 490, 
respectively, which delete the En and D + En domains, respectively (San Filippo and 
Lambowitz 2002). Protein concentrations were determined by Bradford assay (Bradford 
1976), using LtrA protein whose concentration had been determined by using A280 as a 
standard. The protein preparations were >98% pure, as judged by Coomassie blue-stained 
SDS-polyacrylamide gels. 
Ll.LtrB-!ORF lariat RNA was generated by self-splicing of a 971-nt Ll.LtrB RNA 
(902-nt Ll.LtrB intron flanked by 5’- and 3’-exon sequences of 32 and 37 nt, 
respectively) transcribed from BamHI-linearized pJN!ORF with phage T7 RNA 
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polymerase, using a MEGAScript kit (Ambion) (Noah and Lambowitz 2003). Self-
splicing was carried out with 2 µM Ll.LtrB-!ORF RNA in 1 ml of 0.5 M NH4Cl, 50 mM 
MgCl2, 40 mM Tris-HCl, pH 7.5 at 30°C. After renaturing the RNA by heating to 50°C 
for 1 min and then slowly cooling to 30°C in 0.5 M NH4Cl, 5 mM MgCl2, 40 mM Tris-
HCl, pH 7.5, self-splicing was initiated by adding the remaining MgCl2. The reaction was 
incubated for 2 h at 37°C and terminated by extraction with phenol-CIA. 
 To reconstitute RNPs, the LtrA protein was incubated with the in vitro self-
spliced lariat RNA in 15 ml of reaction medium containing 0.5 M NH4Cl, 5 mM MgCl2, 
40 mM HEPES, pH 7.5. The RNA (3 nmoles in 1 ml of reaction medium) was renatured 
by heating to 50°C for 1 min and then slowly cooling to 30°C. After adding LtrA protein 
(9 nmoles), the sample was diluted to 15 ml with reaction medium and incubated for 2 h 
at 30°C. RNPs were then pelleted by centrifugation in a Beckman Ti50.2 rotor 
(Beckman-Coulter; 40,000 rpm, ! 8 h at 4°C). The RNP pellet was dissolved in 300 µl of 
10 mM KCl, 10 mM MgCl2, 40 mM HEPES, pH 7.5, 50% glycerol, aliquoted, and stored 
at < -20°C. A typical RNP preparation contained 88% lariat RNA, as judged by 
electrophoresis in a denaturing 4% polyacrylamide gel. 
3.4.3 DNA integration assay 
 Reactions were carried out by incubating reconstituted RNPs (6 pmol) with gel-
purified DNA substrates (6 pmol) in 100 µl of 10 mM KCl, 10 mM MgCl2, 40 mM 
HEPES, pH 7.5 (Saldanha et al. 1999). The reactions were initiated by adding RNPs, 
incubated for 5 or 30 min at 37°C, and terminated by phenol-CIA extraction and ethanol 
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precipitation. The products were analyzed in a denaturing 4% polyacrylamide gel, which 
was scanned with a PhosphorImager. 
3.4.4 Atomic force microscopy 
 For AFM, 6 pmol of RNPs (based on RNA A260) were incubated with 6 pmol of 
target DNA in 100 µl of 10 mM KCl, 10 mM MgCl2, 40 mM HEPES, pH 7.5 for 5 or 30 
min at 37°C, then placed on ice. Samples were adsorbed onto aminosilane-modified mica 
surfaces using a slight modification of the procedure described in by (Balagurumoorthy et 
al. 2002). Freshly cleaved mica was exposed to the vapor of 3-
aminopropyltriethoxysilane (98%; Sigma-Aldrich) for 1 h, then baked for 1 h at 100°C. 
After diluting RNP-DNA complexes to 650 pM in 10 mM KCl, 10 mM MgCl2, 40 mM 
HEPES, pH 7.5, a 200 µl aliquot was applied to the treated mica slide, incubated on ice 
for 20 min, washed once with 500 µl buffer, twice with 500 µl water, and air dried. AFM 
imaging was done in tapping mode using a MFP-3D scanning probe microscope (Asylum 
Research, Santa Barbara, CA). Super Sharp Silicon 225 µm tips (SSS-NCLR or SSC-
NCL, Nanoworld, Neuchatel, Switzerland) with a 190 kHz frequency were used for 
imaging. We discerned no difference in resolution with the different tips. 
DNA bend angles were measured using Scion Image software (Scion, Frederick, 
MD). Only complexes that were completely visible and could be traced unambiguously 
were used for analysis. Selected images of single complexes were enlarged and two 
tangential lines were drawn along the center of the protruding DNA arms on both sides of 
the globular RNP, to give the measured bend angle. The angles were defined by manually 
determining the path of the DNA segments exiting the RNP within about 15 nm on each 
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side (Janicijevic et al. 2003). For naked DNA, a circular mask about the size of the RNP 
was placed over the center of the DNA, and the DNA bend angle at this position was 
determined as described above The angle apex was chosen as the point were the DNA 
path trajectories intersect. In each case, the DNA bend angle was calculated from 
measurements of 100 molecules, and the values are expressed as the mean ± the standard 





Figure 3.1:  DNA bendability profiles of the wild-type Ll.LtrB intron DNA target site 
compared to  non-wild-type retrohoming sites, retrotransposition sites, and random 
DNA 
 
The profiles show average bendability versus nucleotide position calculated for sets of 66 
previously identified Ll.LtrB intron retrohoming sites (red line) and 33 Ll.LtrB intron 
retrotransposition sites (blue line). The bendability profiles were compared to those for 
100 control sets consisting of the same number of randomly selected E. coli DNA 
sequences (6600 and 3300 individual sequences, respectively). The profiles for the 100 
retrohoming control sets are shown as light blue lines. The profiles for the 100 
retrotransposition control sets are similar to those for the retrohoming control sets and are 
not shown in order to simplify the figure. Bendability profiles were calculated over a 6-
bp sliding window for positions -30 to +10 from the intron-insertion site by using an 
algorithm that employs a probabilistic model based on DNase I-susceptibility of different 
trinucleotides. Dots mark the nucleotide position at the 5’-end of six-bp segments that are 
significantly more bendable in the retrohoming or retrotransposition sites than in their 
respective control sets, as determined by a statistical test for the difference between two 
sample means using a 5% significance level. The calculated bendability profile for the 
wild-type Ll.LtrB intron DNA target site (dashed line) is shown for comparison (note 





Figure 3.2: Schematic of DNA substrates used in AFM experiments 
 
Substrates are ~240-bp double-stranded DNA molecules generated by PCR. The wild-
type Ll.LtrB DNA target site (positions -30 to +15 relative to the intron insertion site) is 
shown as a gray rectangle, with black shading showing regions changed in mutant DNA 
substrates. In DNA substrate L, the wild-type Ll.LtrB intron target site is moved near the 
5'-end of the DNA molecule. Triangles above and below denote the intron insertion site 






Figure 3.3: Reverse splicing and bottom-strand cleavage assay with DNA substrates used 
for AFM 
 
Wild-type or mutant Ll.LtrB RNPs were incubated with internally 32P-labeled DNA 
substrates (Figure 3.2) for 5 min (lane 2) or 30 min (lanes 3-10) at 37°C and the products 
were analyzed in a denaturing 4%  polyacrylamide gel. Lane 1 shows the WT DNA target 
substrate incubated in reaction medium for 30 min at 37°C without RNPs. The substrates 
used in the reactions for lanes 2-10 are indicated on the far left. Positions of products 
resulting from partial and complete reverse splicing and bottom-strand cleavage are 





Figure 3.4: Representative AFM images of RNP-DNA complexes with WT and L DNA 
substrates 
 
AFM images of wild-type Ll.LtrB RNPs bound to DNA substrates in which the Ll.LtrB 
intron target sequence is at the center (WT) or one end (L) of the DNA molecule, 
respectively (see Figure 3.2), taken in tapping mode over a single µm2. The scale to the 
right of the images denotes the sample height in nm and is consistent throughout all AFM 





Figure 3.5: AFM image of free Ll.LtrB RNPs 
 
The figure shows a representative field of RNPs (above) imaged as in Figure 4, after 
incubation in 10 mM KCl, 10 mM MgCl2, 40 mM HEPES, pH 7.5 for 5 min at 37°C. The 






Figure 3.6: AFM imaging of complexes formed with wild-type Ll.LtrB RNPs and DNA 
substrate for different times 
 
WT DNA substrate was incubated with Ll.LtrB RNPs for 5 min at 37°C, and 30 min at 
37°C and imaged by AFM. Partial field views (0.4 !m2) are shown for each. The 
expanded views of single complexes for each time point highlights a RNP-DNA complex 
with a representative DNA bend angle at that time point, 78° at 5 min and 90° at 30 min. 
The histograms on the right of each image show the distribution of DNA bend angles in 
100 complexes for each time point. Gray shaded bell-curves show the bimodal 





Figure 3.7: AFM images of naked DNA substrates 
 
WT and -30/+15 DNA substrates in the absence of RNPs were imaged by AFM. Partial 
field views (0.8 !m x 0.4 !m) are shown for each. The histograms to the right of each 
image show the distribution of DNA bend angles of 100 molecules. The range of DNA 
bend angles of the WT DNA substrate includes larger angles than those observed with the 
-30/+15 DNA substrate, perhaps reflecting the greater inherent bendability of the wild-







Figure 3.8: AFM images of RNP-DNA complexes with disrupted 3'-exon interactions 
 
To determine the effect of disrupting RNP interactions with 3'-exon of the DNA target 
site, two sets of DNA-RNP complexes were used. First, wild-type Ll.LtrB RNPs were 
incubated with the +4/+15 DNA substrate, which has disfavored nucleotide-residues at 
3'-exon positions +4 to +15, and imaged by AFM. Next, WT DNA substrate was 
incubated with !En RNPs, which are reconstituted with a mutant LtrA protein lacking the 
C-terminal En domain, and were imaged by AFM. The histograms to the right of the 
images show the distribution of DNA bend angles in 100 complexes for each condition. 
DNA bend angles in both sets of complexes with disrupted 3'-exon interactions are 
distributed similarly to that of naked (unbound) DNA (Figure 3.7). All incubations were 






Figure 3.9: AFM images of RNP-DNA complexes with nicked DNA substrates 
 
Wild-type Ll.LtrB RNPs were incubated with WT and +4/+15 mutant DNA substrates, 
both containing a pre-positioned nick at the bottom-strand cleavage site, for 30 min at 
37°C and imaged with AFM. The histograms to the right of the images show the 
distribution of DNA bend angles in 100 complexes for each nicked DNA substrate. The 
distribution of DNA bend angles in complexes with the nicked WT DNA substrate 
mirrors that of complexes with non-nicked WT DNA substrate with two predominate 
clusters of angles at approximately 75° and 90° (Figure 3.6, 30 min). The DNA bend 
angles in complexes with the nicked +4/+15 DNA substrate are broadly distributed 
mirroring the distribution of DNA bend angles in complexes with the non-nicked +4/+15 






Figure 3.10: AFM images of RNP-DNA complexes after initiation of reverse 
transcription 
 
Wild-type Ll.LtrB RNPs were incubated with WT DNA substrate at 37°C in the presence 
of 2 µM each dATP, dTTP, and dCTP for 5 and 30 min, respectively, and imaged by 
AFM. The highlighted molecules illustrate the predominant bend angle at each time, 78° 
at 5 min and 90° at 30 min. With wild-type RNPs the presence of dNTPs skews the 
distribution of DNA bend angles toward the larger angle (90°) at 5 min compared to 
complexes imaged in the absence of dNTPs (Figure 3.6). The distribution is even more 
heavily skewed toward the 90° bend angle with wild-type RNPs in the presence of 






Figure 3.11: AFM images of RNP-DNA complexes with RT-deficient LtrA protein 
 
Ll.LtrB RNPs reconstituted with the DD- LtrA mutant were incubated with WT DNA 
substrate at 37°C in the presence of 2 µM each dATP, dTTP, and dCTP for 30 min and 
imaged by AFM. These complexes do not show the same DNA bend angle distribution 
pattern as those with wild-type RNPs. In a large population of these complexes, the DNA 





Figure 3.12: DNA bending during Ll.LtrB intron retrohoming 
  
(1) RNPs bind DNA non-specifically and search for target sites. (2) Initial DNA target 
site recognition involves IEP interactions with the distal 5’-exon region and base pairing 
of the intron RNA’s EBS2, EBS1, and ! sequences to the IBS2, IBS1, and !’ sequences 
between positions -12 to +3 of the DNA target site. These initial DNA target site 
interactions and reverse splicing of the intron RNA into the intron-insertion site (IS) in 
the DNA top strand do not lead to detectable DNA bending. (3) Subsequent IEP 
interactions with the 3’-exon lead to an initial DNA bend angle of 75° and bring the 
scissile phosphate at the bottom-strand cleavage site (CS) to the En active site. (4) Shift 
of the 3’-end of the cleaved bottom strand from the En to RT active site for initiation of 




Chapter 4: Gene targeting in Bacillus subtilis using reprogrammed 
Ll.LtrB introns 
 
Reprogrammed Ll.LtrB group II introns (“targetrons”) have been used for site-
specific insertion and gene disruption in a variety of organisms (Karberg et al. 2001; 
Perutka et al. 2004; Yao et al. 2006; Yao and Lambowitz 2007; Mastroianni et al. 2008). 
Here, I demonstrated the suitability of targetrons for gene targeting in the Gram-positive 
bacterium, B. subtilis by the insertion of the intron into two genes, yhcS and ywpE. These 
two genes where chosen because each has a corresponding homolog in pathogenic Gram-
positive species such as the closely related Bacillus anthracis (Comfort and Clubb 2004). 
Recently, interest has grown in the B. anthracis homologs of yhcS and ywpE, srtA and 
srtB, respectively, due to their role in bacterial virulence (Zink and Burns 2005; Maresso 
and Schneewind 2008).   
These genes encode sortase enzymes, which are transpeptidases responsible for 
anchoring proteins to the bacterial cell wall. The yhcS/srtA gene product, Sortase A 
(SrtA), is a general house-keeping enzyme responsible for attaching a variety of protein 
types to the cell wall (Comfort and Clubb 2004; Dramsi et al. 2005). The ywpE/srtB gene 
product, Sortase B (SrtB), specifically anchors proteins involved in iron acquisition to the 
cell wall (Marraffini et al. 2006; Maresso et al. 2008). Certain mutations in either protein 
can dramatically inhibit bacterial growth in mouse macrophage cells, but sporulation and 
growth in BHI medium are unaffected (Zink and Burns 2005). This phenotype makes 
these proteins attractive drug targets because germination of B. anthracis spores in 
 99 
alveolar macrophages is critical in the infectious progression of inhalation anthrax 
(Guidi-Rontani et al. 1999).  
Although closely related to B. anthracis, B. subtilis is non-pathogenic. B. subtilis 
was used here as a model for the application of targetrons in Bacillus genus gene 
targeting. Both SrtA and SrtB have been reported to be non-essential for B. subtilis 
growth in culture media (Kobayashi et al. 2003). 
4.1 INTRON MOBILITY IN B. SUBTILIS 
To test the mobility of the reprogrammed Ll.LtrB intron in B. subtilis, the intron 
and IEP were expressed from the donor plasmid pNL9161, which was used previously 
for gene targeting in Staphylococcus aureus (Figure 4.1)(Yao et al. 2006). pNL9161 is 
efficiently propagated in E. coli, to which it confers ampicillin resistance, then purified 
for electro-transformation into B. subtilis, to which it confers erythromycin resistance. 
The Ll.LtrB intron with flanking 5'- and 3'-exons is expressed using a cadmium-inducible 
promoter. The LtrA protein is also expressed from pNL9161 downstream of the 3'-exon.  
For the B. subtilis genomic mobility assay, expression of the intron/IEP was 
induced with 10 µM CdCl2 at 37°C. Aliquots of the culture were then diluted and plated 
on LB media containing erythromycin. Targeted gene insertions were detected by colony 
PCR using primers that anneal to genomic DNA at positions flanking the insertion site. 
The insertion events were further confirmed by sequencing of the PCR amplification 
products.  
 Suitable target sites were found in both the yhcS and ywpE genes using the 
computer algorithm described in Perutka et al. (2004). One target site from each with the 
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highest predicted efficiency was chosen. The YhcS-186s targetron, which inserts at 
nucleotide position 186 in the sense-strand of the yhcS gene, was inserted into the target 
gene in 91 ± 5% of cells plated following cadmium induction as determined by colony 
PCR (Figure 4.2). Targeting by the YwpE-137a targetron, which inserts at nucleotide 
position 137 in the antisense-strand of the ywpE gene, was not detected in any colonies 
when plated on LB media with erythromycin, but insertion was detected when the 
cadmium-induced bacterial culture was used as a PCR template directly. Based on the 
band intensities of the PCR products from targeted and non-targeted genes in an ethidium 
bromide-stained agarose gel, the apparent targeting efficiency of the YwpE-137a 
targetron was estimated at less than 1%. 
4.2 DISCUSSION 
  As demonstrated, Ll.LtrB group II intron-based targetrons can be used for gene 
targeting in B. subtilis. The two sortase enzyme genes targeted here are homologs of 
potentially important pathogenesis targets in B. anthracis and targeted gene disruption 
using the targetron system may provide a useful technique for the study of these genes. 
 Targeting of the B. subtilis yhcS gene is extremely efficient, with a targeting 
efficiency approaching 100%. As expected for a non-essential protein, the insertion 
events were easily detected on plated colonies after expression of the targetron. The high 
insertion efficiency of the YhcS-186s targetron indicates that the Ll.LtrB intron and LtrA 
protein function normally in B. subtilis when expressed from the pNL9161 donor 
plasmid. 
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 The YwpE-137a targetron is active in B. subtilis, but with a lower apparent 
mobility efficiency than that of YhcS-186s. The ywpE gene product is only a putative 
SrtB protein and it has not been identified as an essential gene (Kobayashi et al. 2003). 
However, I find here that targeted disruption of the ywpE gene prevents colony growth on 
LB plates. The assumed function of the ywpE gene product, as a SrtB enzyme, is the 
attachment of proteins required for iron acquisition, including the secretory machinery for 
siderophores, to the cell wall (Marraffini et al. 2006). Cells with non-functional secretory 
machinery would still have access to siderophores and other secreted proteins when 
grown in the presence of wild-type cells in liquid culture. This may also explain the 
observed phenotype of B. anthracis SrtB mutants that are unable to grow in macrophage 
cells but grow normally in liquid media (Zink and Burns 2005). 
4.3 METHODS 
4.3.1 Recombinant plasmids and bacterial strains 
 The Ll.LtrB-!ORF intron with flanking 5'- and 3'-exons was expressed from the 
plasmid pNL9161 downstream of a cadmium-inducible promoter (Pcad) (Yao et al. 
2006). pNL9161 is derived from the pCN37 plasmid which contains a ColE1 replicon for 
propagation in E. coli and a pT181-cop WT replicon for replication in Gram-positive 
species such as B. subtilis (Charpentier et al. 2004). 
 The B. subtilis strain ATCC6051 used in the mobility assays was provided by Dr. 
Richard Losick (Department of Molecular and Cellular Biology, Harvard University, 
Cambridge, MA).    
 102 
4.3.2 Targetron design 
 The Ll.LtrB-based targetron was retargeted to insert into B. subtilis genes by 
using a computer algorithm that identifies potential insertion sites and designs PCR 
primers for modifying the intron RNA to base pair to those sites (Perutka et al. 2004). 
Single sites in the yhcS and ywpE genes were chosen from among potential target sites 
identified by the algorithm. Donor plasmids were then constructed in which the intron 
RNA's EBS1, EBS2, and ! sequences were modified to optimize base pairing to DNA 
target site sequences IBS1, IBS2, and !'. The IBS2 and IBS1 sequences in the 5'-exon of 
the donor plasmid were also modified to be complimentary to the retargeted EBS2 and 
EBS1 sequences for efficient RNA splicing (Perutka et al. 2004). 
 The required modifications were introduced into the donor plasmid via two-step 
PCR as described in Karberg et al. (2001). First, two segments of the donor plasmid were 
amplified by PCR. One PCR used primers p1 (5'-exon positions -25 to +18 with 
modifications at positions -12 to -1 for IBS1 and IBS2) and p2 (5'-
CGAAATTAGAAACTTGCGTTCAGTAAAC-3'). The other PCR used primers p3 
(intron positions +198 to +246 with modifications to positions +223 to +227 for EBS2) 
and p4 (intron positions +259 to +326 with modifications to positions +276 to +285 for 
EBS1 and !). In the second step, the two PCR products from the first step were gel-
purified, mixed, and amplified with primer p1 and p4 (the outer primers) to generate a 
353-bp product which corresponds to the 5'-exon and 5'-end of the intron (to position 
+326) with modified IBS1/2, EBS2 and EBS1/! sequences. The final PCR product was 
gel-purified and cloned between the BsrGI and HindIII sites of the donor plasmid. 
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4.3.3 Gene targeting in B. subtilis 
 The donor plasmids containing the retargeted introns were electroporated in to B. 
subtilis ATCC6051. Cells were grown overnight at 37°C in LB media containing 
erythromycin. 500 !l of the overnight culture was subcultured into 5 mL of fresh medium 
and grown until early log phase (O.D.595 = 0.5). Cells were then either directly plated or 
induced by adding 10 !M CdCl2 for 90 min at 37°C prior to plating. 
 Targetron insertion was assayed by PCR using primers that flank the target genes 
and either single colonies or 1 !l of undiluted induced culture as template. For 
sequencing, the PCR products were run on 1% agarose gel. Bands were excised and 
purified using the Qiagen Gel Extraction Kit (Qiagen, Valencia, CA).  
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Figure 4.1: pNL9161, the targetron donor vector for B. subtilis 
 
The intron donor plasmid pNL9161 uses the cadmium-inducible Pcad promoter to express 
a 940-nt Ll.LtrB intron, flanked by the 5'-exon (E1) and 3'-exon (E2). The LtrA protein is 
expressed from a position just downstream of the 3'-exon. The ColE1 ori allows the 
plasmid to be propagated in E. coli  for purification and transformation into B. subtilis. 
The pT181 cop-wt repC amplicon allows the plasmid to be replicated in Gram-positive 
bacteria, such as B. subtilis or B. anthracis. The plasmid carries the ampicillin resistance 






Figure 4.2: Intron base pairing in B. subtilis gene target sites 
 
The wild-type Ll.LtrB intron target site with EBS-IBS/!-!' base-pairing interactions is 
shown along with the B. subtilis yhcS and ywpE target sites. Target site residues matching 
wild-type are shaded in gray. Black arrowheads indicate the intron-insertion site in the 
top strand and the predicted endonuclease cleavage site in the bottom strand. The 






Figure 4.3: PCR detection of Ll.LtrB integration 
 
PCR using genomic primers flanking the yhcS gene (lanes 1 and 2) and the ywpE gene 
(lanes 3 and 4) was used to detect Ll.LtrB integration. In lane 1, the PCR template was 
provided by a single colony picked from plated cells following RNP expression by 10 
!M CdCl2 induction at 37°C for 1 h. In lane 2, a single colony from plated cells with no 
pNL9161(YhcS-186s) donor plasmid was used. In lane 3, PCR template was provided by 
1 !l of cell culture following RNP expression by 10 !M CdCl2 induction at 37°C for 1 h. 
In lane 4, 1 !l of cell culture with no pNL9161(YwpE-137a) donor plasmid was used. 
Bands corresponding to the targeted gene (lanes 1 and 3) were gel extracted and 
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